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ABSTRACT 
As a leading cause of death worldwide, coronary artery disease affects people of all races and 
ethnicities. The foundation for the prevention of secondary fatal cardiac events, such as stroke 
or myocardial infarction, is lifestyle modification to effectively lower cholesterol levels. Lifestyle 
change impacts diet, physical activity, smoking habits, vital sign measures, and stress 
management. The purpose of this evidence-based practice project was to reduce implement a 
lifestyle intervention to lower LDL-C levels and promote healthier lifestyles. This practice change 
was developed utilizing Stetler’s Research Utilization model to promote evidence-based practice 
changes in the clinical setting. Nola Pender’s Health Promotion model was applied to facilitate 
the implementation of the intervention. A systematic literature search revealed 16 pieces of 
evidence that were used to develop a lifestyle modification program which entailed 
individualized counseling and a patient-guided booklet to facilitate heart healthy lifestyle 
changes. The created patient-guided booklet contains material from this literature as well as the 
American Heart Association and the National Institute of Health. A total of 14 adult participants 
were recruited from a local cardiology practice and were evaluated at their initial evaluation and 
then again 6 months later. The primary outcome measurement was the low- density lipoprotein 
cholesterol (LDL-C) drawn from a fasting lipid panel; secondary outcomes measured were blood 
pressure, body mass index, dietary habits, and physical activity patterns. Paired t-tests were run 
with a significance level set at p <.05. Significant outcomes that were found include dietary 
habits (p =.011) and physical activity patterns (p =.031). There was no significant change in 
LDL-C levels pre- and post- intervention (p =.461). The results of this evidence-based practice 
project will be used to implement a cost-effective, patient-centered strategy in the clinical setting 
to lower a patient’s risk for a secondary cardiac event by changing lifestyle choices.
LIFESTYLE MODIFICATION PROGRAM  
  
 
1 
CHAPTER 1 
INTRODUCTION 
Background  
 Each year cardiovascular disease is the leading cause of mortality in the world with 17.7 
million deaths globally and 610,000 deaths in the United States (WHO, 2018; CDC, 2017). 
Cardiovascular disease encompasses a variety of diseases that affect the heart and peripheral 
vascular structures, such as hypertension, atrial fibrillation, coronary artery disease, heart 
failure, and stroke (AHA/ASA, 2017). Coronary artery disease (CAD) is the most prevalent 
cause of heart disease contributing to 366,000 deaths in 2015 and 28.1 million people 
diagnosed in 2016 (CDC, 2017); 11.5% of adults in the U. S. live with CAD. Risk factors for 
developing CAD include lifestyle choices, family history, high cholesterol (hyperlipidemia), high 
blood pressure (hypertension), and cigarette smoking (CDC, 2015). Other risk factors consist of 
metabolic syndrome, diabetes mellitus Type II, obesity, dyslipidemia, sedentary lifestyle, and 
sleep disorders (Roever, Biondi- Zoccai, & Rao, 2017). Hyperlipidemia is the major modifiable 
risk factor for the development of heart disease that can be managed with lifestyle interventions 
and medications. Several task forces are working to lower the incidence of cardiovascular 
disease through primary and secondary prevention. One of the objectives for the Healthy 
People 2020 initiative is to “improve cardiovascular health and quality of life through prevention, 
detection, and treatment of risk factors for heart attack and stroke” (Healthy People 2020, 2018).   
Statement of the Problem 
 The American College of Cardiology and the American Heart Association (ACC/AHA) 
2018 national guidelines on the treatment of hyperlipidemia incorporate both pharmacological 
and nonpharmacological approaches to reduce patients’ risk for primary and secondary fatal 
cardiac events. A fatal cardiac event is the occurrence of stroke, heart attack, or death. These 
guidelines stress the importance of “lifestyle as the foundation for ASCVD risk-reduction” 
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(ACC/AHA, 2014, p. 2895). Atherosclerotic cardiovascular disease (ASCVD) 10-year risk 
calculator determines the overall risk of heart disease and stroke over a ten-year period and is 
used frequently in the primary and specialty office settings to determine a patient’s cardiac risk 
for those patients who have not had a fatal event or prior diagnosis of CAD (ACC, 2018).  Not all 
providers discuss the important benefits of making healthy lifestyle choices and maintaining that 
lifestyle. If adult patients with CAD are not only prescribed statin-therapy but also given dietary 
advice regarding national recommendations for a heart healthy diet and adequate physical 
activity, there would be decreased hospitalizations and fatal cardiac events, prolonging the 
longevity and quality of life in this population.  
 Hyperlipidemia in adult patients with CAD increases the risk for fatal cardiac events 
which include heart attack, stroke, or death. As a modifiable risk factor, treatment for 
hyperlipidemia involves pharmacological and nonpharmacological therapies. Pharmacological 
therapies include statin therapy as first-line treatment options in conjunction with lifestyle 
modifications such as dietary changes, physical activity, stress management, and weight 
management (AHA, 2017). The overall aim of these therapies is to decrease the low-density 
lipoprotein cholesterol (LDL-C). Unfortunately, there is difficulty achieving this treatment goals 
and lifestyle modifications in the clinical setting. The need for a lifestyle change intervention 
regarding dietary changes and physical activity is evident throughout the literature. 
Data from the Literature Supporting Need for the Project 
 According to Cardoso, Moraes, Rosa, & Moreira (2015) only 14% of patients actively 
follow guideline recommendations. As the leading cause of death worldwide and across the 
nation, the United States Preventive Services Task Force (USPSTF) (2014) encourages 
providers to prevent the occurrence of hyperlipidemia in overweight or obese patients with 
“intensive behavioral counseling interventions to promote a healthful diet and physical activity 
for cardiovascular (CVD) prevention”. This guideline is given a grade B as a recommended 
practice.  
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According to Heaton & Frede, 2006, Voogdt-Pruis, Van Ree, Gorgels, & Beusmans, 2011, 
healthcare providers have fallen short due to time and resource constraints. HealthyPeople 
2020 released objectives with solutions to reduce the number of deaths from coronary artery 
disease (from 129.2 per 100,00 people in 2007 down to 103.4 per 100,000 in 2020) and reduce 
the overall number of adults with high cholesterol (from 15.0 per 100,000 down to 13.5 per 
100,000 in 2020) by adhering to heart healthy diets and incorporating physical activity 
(HealthyPeople, 2014). In addition to lifestyle factors, patients with established CAD should be 
prescribed statin therapy for treatment and protection. 
 As a worldwide epidemic, coronary disease is monitored by global task forces to reduce 
incidence and monitor prevalence. A cross-sectional study that surveyed twenty-four European 
countries (EUROASPIRE IV) showed providers are still lacking application of lifestyle 
modification recommendations for the secondary prevention of cardiac events. Even in those 
patients taking lipid lowering agents alone, medication needs the support of healthy lifestyle 
changes (Kotseva et al., 2016). In addition, a retrospective, randomized control trial study 
analyzed the factors influencing physician counseling on cardiovascular risk. The results 
revealed, regardless of blood pressure readings and lab results, overt signs of obesity, 
appearance and weight, were the driving factor for lifestyle counseling (Rakita, Homko, 
Kashem, Memon, & Bove, 2016). Therefore, not all patients received adequate counseling 
regarding lifestyle modifications to reduce the risk or burden of coronary disease. With the many 
tools available from the AHA, providers are not taking advantage of using them during follow up 
visits (AHA, 2018).  
Data from the Clinical Agency Supporting Need for the Project 
 CAD is not just prevalent world and nationwide, but also significant locally as the CDC 
reports numbers in comparison to the national average. In Lake County, Indiana, there were 
190.4 deaths per 100,000 people ages 35 and older from 2013-2015, which compares to the 
national average of 194.5 deaths per 100,000 people (CDC, 2018). A local cardiology practice 
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that serves the population of Lake County, Indiana, and is a part of a larger, non-profit 
healthcare system sees approximately 78 patients per week with a variety of patients with 
cardiovascular diseases. The struggle of managing patients with multiple comorbidities has 
become overwhelming to healthcare providers. Providers focus on emergent issues at follow-up 
visits, and time is not always spent counseling on preventive care. According to the 2013 
ACC/AHA guidelines on the treatment of blood cholesterol and lifestyle counseling, modification 
should precede and work in conjunction with pharmacological therapies to lower LDL-C levels. 
Although current recommendations do not set a specific LDL-C target goal, the cardiologist 
prefers 50% of baseline or less than 70 mg/dL. Patients with CAD are also prescribed statin 
therapy for treatment, and in some cases, patients are even referred to a dietician. The 
cardiologist at this clinical site provides usual care in accordance with national guidelines and 
patient preferences to enforce secondary prevention in CAD. Due to time constraints and lack of 
meaningful resources, lifestyle counseling is not always provided during local office visits for 
CAD patients struggling with hyperlipidemia. 
 The healthcare providers at this site would like to incorporate the patient in shared-
decision making and mutual goal setting to promote healthy lifestyle habits. The healthcare 
providers at this site agree nonpharmacological approaches to meet clinical guidelines need to 
be a priority in patient care and welcome the opportunity to improve upon their current practice. 
The application of evidence-based practice (EBP) in this particular clinical setting meets the 
national recommendation guidelines and priorities of these healthcare providers. Also, there is a 
lack of resources at this clinical site to discuss these changes with patients, hindering the 
opportunity to outline major lifestyle contributors and guide the patient to healthier lifestyle 
behaviors. This project counseled and supplied patients with the necessary materials from the 
AHA and NIH to promote self-managing behaviors to lower LDL-C levels and the overall risk for 
a fatal or nonfatal cardiac event.  
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Purpose of the Evidence-Based Practice Project 
 The impact of lifestyle behaviors is evident by the lack of lipoprotein control and 
evidence of fatal or non-fatal CAD events. The purpose of this EBP project is to implement a 
lifestyle intervention to lower LDL cholesterol and promote healthier lifestyles. Participants were 
counseled on lifestyle modifications, after assessing their current lifestyle choices, using 
materials emphasized in the national guidelines. The focus of this counseling was to target 
lower LDL cholesterol levels below 70mg for high-risk and less than 100 mg for low/moderate 
risk adult patients with CAD in a way that is effective and time-efficient. Focusing on lowering 
these cholesterol levels by targeting lifestyle modifications lowered cardiovascular risk, thus 
reducing patient’s risk for a major cardiac event. Secondary outcomes included measuring 
effects on blood pressure, body mass index (BMI), and dietary and physical activity changes. 
Compelling Clinical Question  
 The compelling question that was answered over the length of this project was focused 
on the effectiveness of a lifestyle intervention that aids in pharmacological therapy (if applicable) 
to improve cholesterol levels in adults with coronary heart disease. Although there are various 
diets available for patients to follow, the ACC/AHA (2013) recommends a “heart healthy diet” for 
lowering adult LDL-C. A heart healthy diet consists of decreasing dietary fat (especially 
saturated and trans fat) intake and increasing intake of vegetables, fruits, and whole grains 
(Eckel et al., 2014). Other important foods to incorporate into a heart healthy diet are low-fat 
dairy products, poultry, fish, legumes, non-tropical vegetable oils, and nuts. Necessary 
eliminations include refined sugars, which are found in most bakery items and beverages, and 
red meat, from beef and lamb. These changes will be made through following the DASH dietary 
plan (Dietary Approach to Stop Hypertension).  
 In addition to dietary recommendations, physical activity is another crucial component to 
reaching lower LDL-C levels. Eckel et al. (2014) advises adults to participate in 40-minute 
moderate-to-high intensity aerobic exercise 3-4 times per week. As a result, Eckel et al. (2014) 
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estimated that 6% of CAD could be eliminated worldwide with life expectancy to increase by 
0.68 years with the incorporation of physical activity. Patients also take lipid-lowering 
medications which help maintain therapeutic LDL-C levels. Statin therapy, which is a first line 
therapy for lipid reduction, varies by intensity, based on patient’s cardiovascular risk and 
medical history; high-intensity statin therapy should be prescribed for patients less than 75 
years of age who have CAD (Stone et al., 2014). Lifestyle modifications (diet and physical 
activity) and lipid-lowering medial therapy complement one another to achieve optimal results. 
Will there be clinical significance to focus more on health-promoting behaviors as the guidelines 
and current literatures insists?  
PICOT Question 
 The PICOT clinical question that was evaluated is: in adult patients with CAD, does 
dietary and physical activity counseling with a lifestyle intervention lower cholesterol levels in six 
months? 
Significance of the EBP Project 
 With the projected increase of cardiovascular diseases, the AHA/ASA (2017) predicts by 
the year 2035, half of the United States population will have some form of cardiovascular 
disease. This disease costs healthcare systems a significant amount of money and time when 
caring for these patients. In 2016, cardiovascular disease cost the nation $555 billion and is 
projected to drastically increase to $1.1 trillion by the year 2035 (ACC/ASA, 2017). More 
specifically, CAD contributes $89 billion to these medical costs, making it the most expensive of 
the cardiovascular diseases. Considering the cost of CAD, actions must be taken to reduce the 
burden through primary and secondary prevention.  
 The overall significance of this project will be to apply EBP in a meaningful way that 
impacts local practice to adopt a useful clinical lifestyle intervention. Targeted outcomes 
included lower LDL-C levels, therapeutic blood pressure, weight loss and maintenance, 
improvement in dietary choices, and physical activity adherence. These outcomes were 
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measured with fasting serum lipid panel, blood pressure readings from office 
sphygmomanometer, BMI calculations, Rate-Your-Plate for Blood Cholesterol Tool, and The 
Rapid Assessment of Physical Activity Tool. After the implementation and evaluation of this EBP 
project, patients were empowered to possess better self-management skills over their disease 
and implement ways to improve their cardiac health. The providers are able to utilize a 
resource, that is time efficient and cost-effective, yet patient-centered, in the clinical setting; 
thus, preventing any long-term effects for CAD patients with hyperlipidemia. Ultimately, this 
improves quality of services, cost of implementation, and access to a lifestyle intervention.  
CHAPTER 2 
THEORETICAL FRAMEWORK, EBP MODEL, AND REVIEW OF LITERATURE 
Theoretical Framework 
Overview of Nola Pender’s Health Promotion Model 
 As a nursing theory in the context of health promotion, Nola Pender’s Health Promotion 
Model (HPM) will be applied to this EBP project. Based on self-regulatory and self-reflective 
concepts from Bandura’s Social Cognitive Theory, Pender’s first draft was published in 1982 
with several revisions since then (George, 2011; Pender, Murdaugh, & Parsons, 2015). The 
nursing metaparadigm consists of the four concepts: the patient, health, environment, and 
nurse; this concept is essential and evident in Pender’s work. The definition of health varies per 
patient as either absence of disease, optimal functioning, or a more abstract definition that 
changes over time. Determinants of health include age, socioeconomic elements, culture, and 
environment, which are inseparable from other life situations (Pender et al., 2015).  
 Three assumptions of the HPM are: the patient seeks help from the healthcare provider 
to reach optimal levels of health, has the ability to reflect on past experiences and make rational 
decisions regarding future decisions, and patients must have the desire for positive health 
experiences that produce healthy outcomes. Patients must possess self-regulation over lifestyle 
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choices and constantly interact with the environment in a dynamic way that changes over time. 
Healthcare providers have a significant role in the environment that helps facilitate change, but 
the patient must initiate health-related changes as a result of interaction with the environment, 
which is essential to behavior change (George, 2011). The concept of health promotion and 
behavior change are the overarching concepts of this model, but there are several minor 
concepts also developed in this framework. These major concepts include: a) individual 
characteristics and experiences (prior related behavior and personal factors), b) behavior-
specific cognitions and affect (perceived benefits of action, perceived barriers to action, 
perceived self-efficacy, activity-related affect, interpersonal influences, situational influences, 
commitment to a plan of action, and immediate competing demands and preferences), and c) 
behavioral outcome (health promoting behavior) (Pender et al., 2015).  
 The major concept of individual characteristics and experiences that influence health 
behaviors. These minor concepts that stem from individual characteristics and experiences are 
prior-related behaviors and personal factors. A patient’s prior-related behaviors predict future 
behaviors and decisions; perceived benefits influence the likelihood of a behavior being 
repeated, thus being able to predict outcomes while considering barriers of prior-related 
behaviors (Pender et al., 2015). The nurse’s essential role “helps individuals shape a positive 
behavioral history for the future by focusing on the benefits of a behavior, teaching how to 
overcome hurdles to performing the behavior, and building high levels of efficacy and positive 
affect through successful performance experience and feedback” (Pender et al., 2015, p. 36).  
 Personal factors help predict behavioral actions based on biological factors (age, sex, 
BMI, and family and medical history), psychological (current self-esteem, motivation, and 
perception, and socioeconomical (race, culture, education, and socioeconomic status) (Pender 
et al., 2015). These factors promote the incorporation of the nursing metaparadigm and are 
individualized per patient that impact current state of health. They need to be analyzed and 
incorporated into the intervention as means to fulfill patient’s commitment to action plan.  
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  The essential core concept of behavior specific cognitions and affect influences the 
health-promoting intervention and must be measured to determine if the specific intervention 
caused the behavioral change. Following the minor concepts include perceived benefits of 
action, perceived barriers to action, perceived self-efficacy, activity-related affect, interpersonal 
influences, situational influences, commitment to a plan of action, and immediate competing 
demands and preferences. The perceived benefits of action should focus on the positive 
aspects of health-promoting behavior, because beliefs in positive outcomes, leads to better 
outcomes (Pender et al., 2015). If the patient perceives they can perform a health-promoting 
behavior, they will be motivated toward self-efficacy through intrinsic and extrinsic benefits 
which creates more awareness.  
 Perceived barriers to action are “viewed as mental blocks, hurdles, and personal costs of 
undertaking a given behavior” that need to be addressed as soon as possible to revise the 
action plan (Pender et al., 2015, p. 37). These barriers may include cost, time, transportation, or 
stress. It is essential to discuss barriers to form an action plan that accommodates the patient to 
overcome potential barriers to action. A big component of the HPM is the patient’s ability to 
comprehend and initiate health-promoting behaviors. Perceived self-efficacy consists of 
judgement of skill and critical thinking to plan for certain outcomes and can increase patient’s 
motivation to participate in a particular skill in which they excel (Pender et al., 2015).  This 
concept increases the benefit of the action and is encouraging to the patient, as it increases 
positive thoughts of confidence and competency. Increased perception of self-efficacy motivates 
the patient directly by intensifying the affects to pursue a commitment to plan of action.  
 The activity-related affect consists of the emotional response to a health-promoting 
intervention, which is dependent upon self-acting and the environment (Pender et al., 2015). 
How the patient feels after completing a health-promoting behavior determines whether or not 
the action will be repeated or continued in the future. As previously stated, emotions and 
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feelings happen prior, during, and following an intervention, and if the response is positive, the 
behavior will most likely be repeated.  
 Interpersonal influences consist of the thoughts and actions of others. These influences 
originate from family, friends, peers, coworkers, and healthcare providers (Pender et al., 2015). 
Other thoughts about one’s health and opinion over perceived benefits impact patient’s 
expectations and behaviors; some influences come from social expectations and norms, peer 
pressure, social support, and modeling behavior from others. These influences may result in 
either pressure or encouragement to participate in health promoting behaviors.  
 Situational influences are factors from the available options, details of the health-
promoting intervention, and environmental factors. Patients are more comfortable and 
competent in environments in which they feel “compatible, related, and safe and reassured” 
(Pender et al., 2015, p. 38). This concept provides insight to providing patient-centered care.. 
Situational influences must be re-evaluated throughout the implementation phase for 
maintenance in each patient’s unique, individual characteristics and experiences.  
 The commitment to a plan of action is the initiation of the patient to engage in the health-
promoting intervention, unless there are competing demands that affect participation (Pender et 
al., 2015). Patients are more willing to participate in organized rather than unorganized, 
unplanned lifestyle change behaviors. Two underlying assumptions of cognitive processes are 
the implementation intention with a given time and place, either alone or with support and 
defining concrete strategies for initiating and performing health promoting behaviors. There 
must be a mutual agreement between the healthcare provider and patient to set a plan of action 
and strategy to motivate and “reinforce health behaviors according to individual preferences” 
(Pender et al., 2015, p. 39). This agreement brings the patient to a realization of the critical 
health behavior change and establishes a commitment to follow through with the behavior due 
to interpersonal influence. 
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 Immediate competing demands and preferences are types of demands and preferences 
that distract or take precedent over the initiation or maintenance of health-promoting behavior 
(Pender et al., 2015). Patient usually have little or no control over these feelings, they are not to 
be confused with barriers. Competing demands and preferences occur in the moment. This 
concept is evident by the patient’s behavior changes in relation to the health promoting behavior 
and desirable health goals. Health promoting behavior is the finish line or end point of the HPM. 
Ending at this point prepares the patient for continual maintenance of behavior which improves 
overall health status, quality of life, and functioning (Pender et al., 2015). At this point, the 
patient has established health-promoting behavior and may even influence others through 
modeling and feedback to influence them to also achieve this endpoint of self-efficacy over 
health behaviors. This concept is the overall goal and requires continual maintenance with 
feedback from the provider.  
Application of Theoretical Framework to EBP Project 
 The application of Pender’s HPM is appropriate for the context of this EBP project and 
measurable outcomes in clinical practice. Since the basis of lowering LDL-C levels is based on 
the health-promoting behaviors of making heart healthy decision in regards to food consumption 
and incorporating physical activity into sedentary lifestyle, the concepts of the HPM are 
applicable to patients seen in this outpatient cardiology clinical office. According to Pender et al. 
(2015) strategies to impact behavior change would involve raising awareness of CAD and fatal 
events, re-evaluation of self, setting goals that focus on shared-decision making with patient, 
promoting self-efficacy to guide the patient toward health promoting behaviors, enhance the 
benefits of change by achieving baseline LDL-C levels to show the magnitude of progress, 
recognizing cues to promote change, and managing barriers to change.  
 Understanding a patient’s perception of self-efficacy influences the patient’s ability to 
participate in a lifestyle modification treatment plan. If they perceive they cannot do it based on 
their previous attempts and inept skills, then chances are they have low self-efficacy and may 
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need reassurance on their current abilities and where to start. Prior poor dietary and physical 
activity habits lead to undesirable health outcomes and the progressive advancement of CAD. 
The project manager’s role was to assess previous dietary choices and sedentary lifestyle that 
contributed to the poor control over LDL-C level to anticipate the patient’s future behaviors. 
 The participants of this EBP project were encouraged to focus on their positive intrinsic 
and extrinsic factors to strengthen their self-efficacy. Intrinsic factors will vary per participant and 
will be highlighted during the counseling portion of the intervention. These factors may include 
the way the participant feels about making health-conscious decisions regarding diet and 
physical activity. Extrinsic factors will focus on possible positive rewards or outcomes the patient 
perceives from participating in this EBP project. This process of evaluating intrinsic and extrinsic 
factors consider patient’s age, abilities, current mood or thought process, dietary preferences, 
financial budget, career, and level of education. Patients may have certain preferences based 
on their daily routine and what they are used to. One of the objectives of this project is to 
provide patients with opportunities to make shopping decisions based on comfort level, starting 
one small goal at a time and introducing physical activity into sedentary lifestyles with short 
intervals at a time. 
 Competing demands is an important concept to consider when administering the 
intervention. A patient may be driving home from the grocery store and instead of waiting and 
cooking a heart healthy meal at home, decides to drive through a fast food chain due to the 
immediate preference for fast food. These types of demands and preferences impede patient’s 
ultimate intentions. Some patients may be more distracted than others. The process to 
overcoming these competing demands and preferences requires training and exercising self-
regulating and controlling behaviors. The behavioral outcome consists of the overall health 
promoting behavior, which is the ultimate purpose of this nursing model. 
 After evaluating perceived benefits, overcoming barriers, evaluating situational and 
interpersonal influences, and increasing self-efficacy, the patient will be able to possess better 
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self-management with CAD. Tailoring individualized health-promoting behaviors through dietary 
and physical activity counseling emphasizes patient preferences and provides patient-centered 
care to prolong health maintenance.  
Strengths and Limitations of Theoretical Framework for EBP Project 
 Although the HPM is successfully used in the context of health behavior change, it also 
has theoretical and contextual limitations. One strength of the HPM is the applicability to desired 
intervention in relation to intended outcomes of this EBP project. Adult patients living with CAD 
and hyperlipidemia need a health promoting process to describe and explain the variables of 
their behaviors and how to achieve optimal LDL-C levels. Due to the holistic, individualized 
treatment plan needed to facilitate change for patients, the HPM provides guidance for 
healthcare providers to be a change agent and predict behaviors of the individuals. On the other 
hand, the HPM contains abstract concepts that are individualized to each patient and are hard, 
if impossible, to measure when evaluating for adherence, perception, or efficacy. Also, the large 
number of concepts within the model may be time-consuming, as this is a time efficient 
counseling intervention. Another limitation is the modality of effectively communicating health-
promoting behaviors, as some patients may not want to change. The HPM allows the project 
manager to discuss the various concepts with the patient to set goals and provide guidance for 
overcoming barriers and competing demands or preferences to maintain a healthy lifestyle and 
reduce cardiovascular risk. 
Evidence-based Practice Model 
 The model used for this EBP process was Stetler’s model for Research Utilization.  
The core of this model is critical thinking and systematic research utilization into EBP. 
Overview of the Stetler Model 
 Nursing theory and nursing models of EBP are essential to achieve supportable 
outcomes in EBP projects. The Stetler model for Research Utilization (Stetler model) is used to 
guide the EBP process from establishing the clinical problem to evaluating clinical outcomes. 
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The Stetler model’s primary focus is to use the synthesized research findings to implement a 
clinical practice change; this process happens in five phases: the preparation phase (phase I), 
the validation phase (phase II), the comparative evaluation and decision-making phase (phase 
III), translation (phase IV), and evaluation (phase V) (Stetler, 2001). These phases are based on 
the assumptions that each type of evidence is supported for use in the appropriate setting, 
synthesized, translated, and then, evaluated for use “in a manner that is replicable, observable, 
credible, verifiable, or basically supportable for safe and effective use” (Dang et al., 2015, p. 
279).  
 It can also be used by novice to expert practitioners in everyday practice to improve 
upon patient outcomes. Due to the applicability of the model to the clinical problem, this 
particular EBP model was selected based on the previous revision of the Stetler model that 
included external and internal bodies of evidence. The use external evidence is crucial due to 
the emphasis on the ACC/AHA’s clinical guidelines for hyperlipidemia in CAD; this expert 
consensus is widely used in healthcare settings and is the basis for most clinical decisions 
(Melynk & Fineout-Overholt, 2015). Internal evidence is the information obtained from the 
clinical site to establish a clinical problem and use the information from patients and healthcare 
providers to support the clinical problem during the preparation phase. All the way through the 
evaluation phase, the Stetler model is a comprehensive and systematic process that is 
applicable to this EBP project for adult patients with CAD and hyperlipidemia.  
Application of the Stetler Model to EBP Project 
 In the preparation phase, the observed clinical problem was that providers were 
following the ACC/AHA clinical guidelines for hyperlipidemia, but not including all aspects of the 
guidelines. As current practice outcomes have shown, cholesterol screening results have not 
been optimal for patients with CAD. This problem is affirmed through actual observation that 
occurred in the clinical setting and is evidenced by the lack of adherence and less than optimal 
LDL-C results. Validation (phase II) was achieved after a thorough review of the current 
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ACC/AHA national guidelines and a literature search through several databases; these 
searches affirmed the significance of the clinical problem. After validating that hyperlipidemia 
and poor lifestyle choices are a prevalent clinical problem in patients with CAD, the synthesis of 
the literature supported the need for a more individualized treatment plan for these patients. The 
decision to use the findings of the literature search was based on synthesis of the data collected 
to support the basis of this EBP project. The resources were selected based upon their 
appraisal, the level and quality. As a result, the next stage of the process was to transition into 
the translation/application phase to address the need for a lifestyle intervention.  
 To translate the synthesis of the literature into a relatable practice, a change in current 
practice involved a shared-decision making and patient-guided tool. A synthesis of the literature 
summarized the EBP findings and allowed patients to be more self-led through this process by 
encouraging goal-setting and providing resources that support these changes. This approach 
was instrumental to the longevity of health-promoting behaviors. Methods to implement this 
change included formal heart healthy lifestyle counseling and distribution of an interactive 
patient-guided tool. The application of this type of interaction promotes self-efficacy to manage 
the disease long-term, which the literature supports as a present problem. The goals of 
implementing this EBP project were to evaluate a patient-centered, time-efficient, and cost-
effective tool to guide patients toward healthier behaviors that can be used in an outpatient 
cardiology clinical setting. The overall evaluation was the collection of serum LDL-C levels, 
blood pressures, and calculating BMIs at the conclusion of the implementation period to 
compare with the pre-intervention values. Therefore, the focus of applying health-promoting 
behaviors based on EBP was crucial to the success of research utilization within this model.  
Strengths and Limitations of the Stetler Model for EBP Project 
 The Stetler Model is widely accepted and used in nursing research as a means to 
change health practices. Strengths of this model are the applicability to developing a plan of 
action for EBP projects. Also, the systematic flow of the model allows for a step-by-step 
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evaluation of the overall plan and goals for an EBP project. It can be used in formal and informal 
ways, either in direct patient contact through an organization or in everyday clinical practice by a 
practitioner. The information obtained from an EBP project can improve current practice. The 
Stetler model is very complex and has several critical assumptions of the model which may or 
may not be applicable to all users. The use of the model in an informal manner may be too 
subjective and reduce the credibility to other nurse researchers; the lack of knowledge or novice 
of one user may be using the model in an inappropriate manner. However, the Stetler model 
was first published in 1976 and has since upheld its applicability of research findings into EBP 
(Dang et al., 2015).   
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Literature Search 
 To collect the evidence for best practice for CAD patients with hyperlipidemia, a 
thorough literature search was conducted. Several databases were searched, and keywords 
were used in the format of the PICOT question and narrowed down based upon MeSH and 
CINAHL headings. After the best evidence was collected, a level organization and appraisal of 
the evidence was conducted from Melynk and Fineout-Overholt (2015) for the leveling of 
evidence and the Johns Hopkins Nursing Research/Non-Research Evidence Appraisal tool for 
evidence appraisal (Dearholt & Dang, 2014). See Appendix A for complete literary synthesis. 
Sources Examined for Relevant Evidence 
 In a search for the best available resources, the evidence was searched for in the 
Joanna Briggs Institute (JBI), Cochrane, National Guideline Clearinghouse, Medline, and 
CINAHL databases. Keywords of the PICOT question were used in the foundation for the initial 
key searches. In the Medline and CINAHL databases, subject headings were utilized to 
eliminate all possible variations of keyword usage in each of the two databases. Inclusion 
criteria for final review was based on targeted population, intervention, outcomes measured, 
English language, less than five years old, and country (similar to the cultures of the United 
States). Studies were excluded if they were published in any language other than English, older 
than five years, or did not fit the targeted population, intervention, or outcomes. The final search 
resulted in a total of 747 articles from the included databases. Appendix A includes a complete 
literary search and synthesis. Table 1.1 outlines the final results of the literature search. 
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Table 1.1 
Review of the Literature Table 
Database Results Duplicates Reviewed Accepted 
JBI 153 2 10 3 
Cochrane 125 2 4 2 
NGCH 173 1 3 1 
Medline 102 2 18 9 
CINAHL 194 2 6 1 
Total 747 9 41 16 
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 The National Guideline Clearinghouse was searched for widely accepted clinical 
guidelines. The keyword “cardiovascular disease” was used to find the protocol guidelines for 
adult patients with CAD. Limiters in this database were U.S.-based organizations and years 
from 2013-2017. This timeframe was selected to provide the most recent application of EBP. A 
total of 173 guidelines were found with one duplicate and three were reviewed for consideration. 
One widely accepted and used guidelines in clinical practice was used for evidentiary support 
for CAD patients with hyperlipidemia. The other guidelines were based from medical programs 
that applied this national guideline in their protocols for hyperlipidemia and CAD. 
 Then, a search was conducted in the JBI database to find evidence summaries 
consisting of systematic reviews. The best search in the JBI database included of the main 
concepts from the PICOT question, “cardiovascular disease” OR “coronary artery disease” AND 
prevention, and the inclusion criteria listed. A total of 153 results, two were duplicates from other 
databases. Ten results were considered for final review. Two of the three accepted systematic 
reviews originated from an evidence based summary by Huong Nguyen (2017). The third 
systematic review was citation chased from a JBI evidence summary from Fong (2016).  
Furthermore, the Cochrane database of systematic reviews was searched using the keywords 
“cardiovascular disease” OR “coronary artery disease” AND prevention. Date limiters were 
applied to years 2013-2018, and reviews were eliminated from consideration if they did not meet 
the PICOT criteria. The final search yielded 125 systematic reviews, two were duplicates in 
other databases. A total of 4 reviews were considered for final review and two were accepted 
into the best practice model.  
 The Medline and CINAHL databases were searched for the best supportive evidence. 
MeSH headings were used in Medline to include widely used synonyms and eliminate any 
variations in the keywords. The keywords used were MM “cardiovascular diseases” OR MM 
“coronary disease” AND diet* OR nutrition OR lifestyle AND cholesterol OR lipid* OR 
hyperlipidemia AND “physical activity” OR exercise AND MW “risk reduction behavior” OR MW 
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“secondary prevention”. These keywords were used as a result of analyzing the subject 
headings for the included evidence to keep the search consistent. Exclusion criteria included 
date limiters of years 2013-2018 and the English language. This search produced 102 results, 
two which were duplicates found in the other databases, six were considered for final review. 
Nine were accepted to support this project. The CINAHL database was searched using subject 
headings to continue a systematic search. The words MM “cardiovascular diseases” OR MM 
“coronary disease” AND diet* OR nutrition OR lifestyle OR physical activity OR exercise AND 
cholesterol OR lipid* OR hyperlipidemia AND “behavior modification” OR prevention, also using 
subject headings in the final search with English language, years 2013-2018, and scholarly 
(peer-reviewed) journals as limiters. This search had 194 results with two duplicates included in 
the other databases; six were included for the final review and one was accepted for synthesis 
into EBP. This final search concluded all relevant evidence related to the topic of CAD patients 
with hyperlipidemia and best practice to support a lifestyle intervention in EBP. 
 A total of 747 results were included and forty-one abstracts were reviewed. Duplicates 
were excluded from review. During the examination process, each abstract was analyzed to 
determine if they met criteria for this EBP project. Criteria for this EBP project was based on the 
targeted population of adults with CAD, struggling with hyperlipidemia; studies were excluded if 
they targeted CAD patients that had severe chronic disease, i.e. chronic kidney disease, HIV, 
heart failure, etc., and studies that included pregnant women and children were excluded 
because of their lack of connection to the targeted population. Due to the widespread 
prevalence of this disease and its risk factors across the world, patients with diabetes mellitus II 
were considered due to the heavy correlation between type II diabetes mellitus and CAD. 
Primary prevention is a crucial component to preventing CAD; these studies were used for 
application as a protective measure in secondary prevention. Then, studies were reviewed 
based on their relevance to the intended intervention and measurable outcomes.  
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Appraisal of Relevant Evidence 
 A critical appraisal was performed to evaluate the quality of the evidence for validity and 
reliability. To determine the quality of the evidence used to support this EBP project, 
the Johns Hopkins Research and Nonresearch Evidence Appraisal Tool was used to guide the 
appraisal process (Dearholt & Dang, 2014). Studies were appraised not only based on 
relevancy to the PICOT question, but also based on the quality of the study. The evidence 
needed to have a clear purpose statement with goals that defined outcomes appropriate to care 
for patients with CAD and hyperlipidemia. These goals included measurable outcomes or 
descriptive pertinence to patients with CAD. Also, systematic reviews and RCTs needed to have 
a current literature reviews. Systematic reviews contained reproducible search strategies that 
covered more than one database and contained a diagram of eliminated studies but did not 
appraise the strength of evidence or describe the quality of the studies used. Study details and 
synthesized findings needed to be clear and relatable to patient population and outcomes 
measured. Conclusions were gathered based on the results that were applicable to an 
improvement of health-behavior interventions.  
 Ratings were given based on the outcomes of the appraisal questions. High quality (A) 
ratings were given to those reviews and studies that showed purposeful results, sufficient 
sample sizes, definitive conclusions, and consistent recommendations that related to the 
outcomes of this project. Good quality ratings (B) were assigned to those with sufficient sample 
sizes, some control over intervention, and recommendations were based on a mainly 
comprehensive literature review. Low quality (C) ratings were flawed studies or reviews that had 
inconsistent and unclear results, small sample sizes. The supportive evidence consisted of 9 
As, 5 Bs, and 1 C quality rating, collectively displayed in Table 1.2. After the evidence was 
collected, organized, and appraised, the data from the included literature search was 
synthesized and translated into a best practice model to establish the best way to counsel 
patients with CAD and hyperlipidemia.   
LIFESTYLE MODIFICATION PROGRAM  
  
 
22 
Table 1.2  
Evidence Type and Appraisal  
Level Included Quality Design 
I 4 
 
A (3) 
B (1) 
Systematic Review of randomized 
controlled trials (4) 
II 1 A (1) Randomized Control Trial (1) 
III 2 
A (1) 
B (1) 
Quasi-Experimental (2) 
IV 1 A (1) Prospective Cohort Study (1) 
V 2 
B (1) 
C (1) 
Systematic Review of descriptive studies 
(2) 
VI 1 A (1) Cross Sectional Study (1) 
VII 4 
A (2) 
B (2) 
Expert Panel (2) 
Expert Opinion (1) 
Literature Review (1) 
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Levels of Evidence 
 To determine the level of evidence, Melynk and Fineout-Overholt’s (2015) Rating 
System for the Hierarchy of Evidence for Intervention/Treatment Questions was used for the 
literature appraisal. This rating system was used based on the inclusion of keywords from the 
PICOT question and a broader range of levels of evidence to include well-designed case control 
and qualitative studies (Melynk & Fineout-Overholt, 2015). This hierarchy determines the ratings 
from Level I to Level VII. Level I consists of evidence from systematic reviews and meta-
analysis of all RCTs. Level II studies consist of well-designed RCTs. Level III is well-designed 
controlled trials without the randomization of subjects. Level IV is evidence from well-designed 
case-control and cohort studies. Level V includes evidence from systematic reviews that review 
descriptive and qualitative studies. Level VI consists of evidence from single descriptive or 
qualitative studies, and level VII is the expert opinions and/or reports of expert committees. 
Please see Table 1.2 at the end of this section for a summary of the level and appraisal of 
evidence. 
Level I 
 The level I evidence was four systematic reviews by Hooper, Martin, Abdelhamid, and 
Smith (2015), de Waure et al. (2013), Rees et al. (2013), and Cole, Smith, Hart, and Cupples 
(2011). These articles were given a level I evidence within the hierarchy based on the type of 
study that was conducted. Four systematic reviews performed meta-analysis and one review 
consisted of RCTs. The primary and secondary outcomes measured included overall and 
cardiac mortality, fatal and nonfatal cardiac events, diet intake, blood pressure, lipid 
measurements, amount of physical activity, BMI, and self-efficacy. The Hooper et al. (2015) 
systematic reviews consisted of 15 RCTs and 759,000 participants over two years. A significant 
clinical finding from this review was the 13% reduction of CHD events with the decrease in 
saturated fat intake (RR 0.87, 95% CI 0.74 to 1.03). There was also a clinical significance to 
secondary outcomes in LDL-C and systolic and diastolic blood pressure (MD -0.19 mmol/L, 95% 
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CI -0.33 to -0.05, MD -0.19 mmHg, 95% CI -1.36 to -0.97, and MD -0.36 mmHg, 95% CI -1.03 to 
0.32, respectively) with no clear effects on cardiac mortality.  
 In the systematic review with meta-analysis by de Waure et al. (2013), 14 high-quality 
RCTs consisting of lifestyle interventions in patients with coronary disease were examined. The 
trials were evaluated to correlate the impact of lifestyle interventions on the risk for fatal and 
nonfatal CV events over at least six months. These interventions consisted of multifactorial 
lifestyle components (measures to reduce LDL-C, blood glucose, smoking, stress, and weight 
and increase physical activity) and tailored for the individual needs for each patient. This review 
consisted of 6,657 participants, and it measured the number of fatal and nonfatal events (MI, 
revascularization, and death), overall mortality (all causes), and hospital readmissions. The 
authors endorsed the need for secondary prevention programs due to the overall reduction of 
fatal cardiovascular events and overall mortality. Secondary outcomes that were significant 
included improvements in systolic blood pressure and total cholesterol, LDL-C was not 
measured in this review. Fatal CV events were reduced by 18% (RR 0.82, 95% CI 0.69, P = 
0.003), and overall mortality was reduced (RR 0.94, 95% CI 0.83 to 1.06, P = 0.32). A decrease 
in systolic blood pressure (WMD -4.36 mmHg, 95% CI -6.50 to -2.22) and total cholesterol 
(WMD -0.33, 95% CI -0.57 to -0.08) was observed. The indications are significant for the big 
picture in patients with CAD, to reduce the number of fatal and nonfatal cardiac events. The 
impact of these lifestyle interventions lowers the risk factors and are relevant and reliable to 
support lifestyle interventions that are tailored to patient preferences and resources.  
 Dietary advice for reducing CV risk, addressing the effects among healthy people, was 
reviewed by Rees et al. (2013). Rees et al. (2013) reviewed 44 RCTs and used meta-analysis to 
determine the significance of the findings of the included studies. The interventions in the RCTs 
were either verbal or written advice delivered in person by a healthcare professional among 
18,175 participants. The primary outcomes of this study included overall CV risk factors, blood 
pressure, lipids, and biomarkers of dietary intake; secondary outcomes included self-reported 
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dietary intake. The clinical implications from this systematic review after meta-analysis was the 
reduction on systolic and diastolic blood pressure and lipids. Blood pressure was reported in 11 
studies. Systolic blood pressure was reduced by 2.61 mmHg (DM -2.61, 95% CI -3.91 to -1.31), 
and diastolic blood pressure was lowered by 1.45 mmHg (MD -1.45, 95% CI -2.22 to -0.68). 
Lipids were reported in 18 studies with a small, yet significant reduction in total cholesterol of 
0.15 mmol/L (MD -0.15 mmol/L, 95% CI -0.23 to -0.06) and in 13 studies LDL-C was reduced by 
0.16 mmol/L (MD -0.16 mmol/L, 95% CI -0.24 to -0.08). The DASH diet resulted in the largest 
reduction of fat intake, 10.9% (MD -2.39 gm, 95% CI -3.37 to -1.4). Therefore, the pertinent 
outcomes of this review support the need to measure baseline and follow-up serum lab values 
to measure the consistency of dietary effect and adherence, and support a diet-based 
intervention. The DASH diet was used in some of the interventions, which showed the largest 
reduction of saturated fat intake which should be considered when deciding on dietary 
guidelines for patients to follow.  
 Cole et al. (2011) proposed to “determine the effectiveness of lifestyle interventions for 
the secondary prevention of CHD” in their systematic review which included 21 RCTS and 
10,799 participants (p. 2). The duration of the studies was from three months to five years with 
follow up every three months. Primary outcomes measured in the review were all-cause 
mortality, cardiac mortality, nonfatal cardiac events, and hospital admissions. Secondary 
outcomes consisted of diet (total intake of fiber, fruits and vegetables), exercise, blood pressure, 
blood lipid levels, health related quality of life, self- efficacy, and medication adherence. From all 
of those outcomes, 39 out of 51 participants significantly improved dietary intake of fiber and 
reduced intake of sugar, fat, and cholesterol. In 20 studies, physical activity had increased, 
especially in overall workload endurance. Blood pressure was reported in five out of thirteen 
studies with reported benefits at three and twelve months. Five studies reported significant 
improvements in LDL-C. Self-efficacy was reported in one study, at 6 months self-management 
improved. These findings relate to the effectiveness of implementing a lifestyle intervention to 
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lower the risk of fatal and nonfatal events for patients with CAD. Although self-efficacy was 
discussed in one of the RCTs, self-management is an important factor in longevity of a behavior 
change and patients must be willing to continue health-promoting behaviors after the project has 
ended.  
Level II 
 The level II evidence consisted of one well-organized RCT with substantial implications 
for a lifestyle intervention in CAD patients with hyperlipidemia. Applicable findings from the 
Stuart et al. (2013) were based on the effects of using a primary care prevention model and 
telephone-based support. The outcomes measured in this study included LDL-C, waist 
circumference, blood pressure, physical activity, and motivation. This RCT consisted 49 
participants who were at risk for developing CV disease, 26 in the intervention group and 23 in 
the control group. The intervention included distributing a handbook that provided participants 
with dietary meal plans, recipes, and physical activity plans, as well as telephone support from a 
trained healthcare professional. The study lasted twelve weeks. Primary outcomes measured in 
this study were LDL-C, waist circumference, blood pressure, physical activity, and motivation. 
There were no changes in the dose of blood pressure or cholesterol medications for those 
patients prescribed medications during the course of this study.  
 This stability is an important factor to consider for the implementation process and 
effects on lifestyle changes. Results were presented as an estimated mean with a set significant 
P value of < 0.05. The results of the study showed the intervention group had greater reductions 
in LDL-C levels with significant main effect for treatment (F (1, 43) = 15.50, P = 0.0001). Blood 
pressures remained stable throughout the study and had no significant outcomes on either 
systolic or diastolic pressures, F (1,45) = 15.50, P = 0.60 and F (1, 43) = 0.52 mmHg, P = 0.47, 
respectively. Intervention participants experienced weight loss but no significant treatment effect 
on waist circumference.  There was a positive correlation between weight loss and LDL-C (r = 
0.560, n = 26, P = 0.003). These significant outcomes show an effect on dietary and physical 
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activity counseling on biomarkers that measure hyperlipidemia and CV risk factors. Also, no 
medication changes were made during this study for those participants on blood pressure or 
cholesterol lowering medication; this factor is essential to determine whether or not it was the 
intervention or a potential change in medication dose or frequency that caused the significant 
effects on the measured outcomes. 
Level III 
 Level III studies are well-controlled trials without randomization (Melynk & Fineout-
Overholt, 2015). In Noe et al. (2014), the patients followed a lifestyle modification and nutrition 
intervention. They were combined into three groups: Group A consisted of aerobic and 
resistance training sessions four times per week, Group B had two to three times per week, and 
Group C participants had no regular physical activity. A total of 75 participants with CV risk 
factors were enrolled in this study for six months. Primary outcomes measured were blood 
pressure, heart rate, lipid profile, BMI, and exercise tests. BMI significantly decreased, more in 
Group A than in Group B (8.7% versus 5.0%). There was also a reduction in systolic and 
diastolic blood pressure in Group A and Group B; Group A had a greater reduction in systolic 
and diastolic blood pressure than Group B (8.5% and 7.0%; 5.5% and 4.7%). LDL-C had a 
decrease of 29.8% in Group A and 21.2% in Group B. Implications for clinical practice support 
the incorporation of physical activity into a lifestyle modification intervention and monitoring for 
effects on patient’s cholesterol, a major risk factor for a CV event. 
 In the quasi-experimental study by van den Wijngaart et al. (2015), a nurse-led 
multidisciplinary intervention was initiated to improve the CV disease profile in patients with 
CVD. Their purpose was to “evaluate the magnitude of change in various modifiable 
cardiovascular risk factors, such as body mass index, waist, blood pressure, lipid levels, and 
lifestyle parameters, during short- and long-term follow-up” (van den Wijngaart et al., 2015, p. 
707). This study consisted of 176 participants over a three to fifteen-month period with follows 
every third and sixth months. The intervention retrospectively evaluated profile risk of participant 
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and then individualized a treatment plan that involved both medical and lifestyle behavior 
changes based on that risk profile. These participants were then observed over the length of the 
study. The descriptive characteristics at baseline chart review that researchers included in the 
profile consisted of age, gender, blood pressure, BMI, LDL-C, waist circumference, smoking 
habits, alcohol usage, and eating habits. The tests used to measure the effect in this study 
included a pair t- test or chi-squared and differences between groups were measured by a 
univariate ANOVA. At the end of the study, there was a significant reduction in patient’s systolic 
blood pressure (138.3  20.7mmHg to 128.7 17.7 mmHg; p <0.01) and LDL-C (2.55  0.87 
mmol/L to 2.16  0.73 mmol/L; p < 0.01). Unfortunately, BMI increased from 26.6  4.5 kg/m2 to 
27.5  4.8 kg/m2, and patients became less active toward the end of the study. These pertinent 
outcomes should be considered when developing a project based on tailoring patient 
interventions and the process in which to apply health-behavior change. This study also 
contained smoking cessation; there could be a correlation between smoking cessation (-6.7%;  
P < 0.0001) and the increase in BMI.  
Level IV 
 The level IV evidence accepted for this literature search was by Al Mheid et al. (2016); a 
health-partner administered lifestyle intervention was implemented with 711 university 
employees over 2 years- at baseline, 6-months, 1-year, and 2-years. This prospective cohort 
study implemented a counseling intervention provided by a trained health professional; the 
counseling was based on the AHA’s Life’s Simple 7 healthier lifestyle objectives. The outcomes 
measured in this study include vital signs (heart rate, blood pressure, temperature, respirations, 
and oxygen saturation), height/weight, and waist to hip ratio, a lipid panel, and metabolic panel. 
The results of the study showed a decrease in systolic and diastolic blood pressure at 6 months 
(-3.6 mmHg and -2.2 mmHg, p <0.001) and improvements in LDL-C  
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(p <0.001). Also, physical activity increased by 6% at 6 months (P = 0.04) and dietary scores 
increased by 0.46 for those participants with poor baseline diet scores at 6 months (p <0.001). 
These findings support the need for healthcare professionals to be involved and monitor at risk 
patients in either the primary or secondary context. This one-on-one counseling intervention, 
although not within the outpatient clinical setting and pertains to primary prevention, shows 
efficacy of provider-based counseling for decreasing the risk for CV. 
Level V 
 The two level V studies by Salehi-Abargouei et al. (2013) and Tapsell and Neale (2016) 
were systematic reviews that analyzed descriptive studies. Salehi-Abargouei et al. (2013) 
analyzed the effects of the DASH diet on CV disease by summarizing information and 
assessing “the magnitude of the relation between imitating a DASH-style diet and CVDs or its 
major subclass, like CHD, stroke, and HF in prospective cohorts” (p. 2891). This systematic 
review consisted of six cohort studies with 260,000 adults with or at risk for CV disease, and the 
intervention reviewed was imitating a DASH-style diet. The outcomes measured were either 
incidence of CV disease, CAD, or stroke. Three out of the six studies included data in relation to 
CHD; in 144,337 adults eating DASH diets lowered the risk for CAD (RR 0.79, 95% CI, 0.71-
0.88, P < 0.001). The DASH diet has shown efficacy in lowering the risk for CV disease and 
potential fatal outcomes. 
 Tapsell and Neale (2016) evaluated the effect of interdisciplinary interventions on risk 
factors for lifestyle disease and its risk factors. These risk factors are weight, lipid levels, 
glycemic control, and blood pressure. This systematic review and meta-synthesis of sixteen 
studies (7 RCTs, 3 pseudorandomized, and 6 pre- and post- test results without comparisons to 
a control group) and 15,890 adults with chronic disease. The outcomes measured in this review 
were weight, lipid levels, hemoglobin A1c, and blood pressure. The review also synthesized 
characteristic features of successful interventions for lowering risk factors for chronic disease. 
As a result, one out of six studies found greater improvements in blood lipids, and in five studies 
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there were reductions in blood pressures. In addition, exercise and/or behavior modifications to 
dietary advice resulted in significant reductions in body weight. The synthesized features 
showed there were greater effects when there was greater amount of contact between health 
professionals and participants.  
Level VI 
 The level VI evidence for this EBP project was a cross sectional study, known as the 
EUROASPIRE IV study, by Kotseva et al. (2016). The EUROASPIRE IV study was conducted 
by the European Society of Cardiology to identify patient risk factors, describe management 
through lifestyle and drug therapies, and provide an objective assessment of clinical 
implementation of current scientific medical knowledge (Kotseva et al., 2016). It consisted of 
collecting data from medical records (16,426 records) and post hospitalization interviews (7,998 
interviews) at six months. The population of this study included patients less than 80 years old 
with CAD who had a CABG, PCI, or ACS. Lifestyle factors and targeted anthropometric 
measures, i.e. physical activity, waist circumference, blood pressure, LCL-C, smoking habits, 
cardioprotective medications, diabetes, and cardiac rehab attendance. The findings revealed 
physical activity increased by followed advice from a health or exercise professional (23.5%), 
participated in gym attendance or an exercise program (52.8%), and increased overall daily 
physical activity (17.4%). Patients’ knowledge of weight (93.4%) and blood pressure (86.7%) at 
baseline was sufficient, but most patients were unaware of their current cholesterol level 
(48.9%) or waist circumference (29.3%).  
Level VII 
 The level VII evidence consisted of one expert opinion by Drakopoulou et al. (2016), two 
expert panels by Eckel et al. (2014) and Stone et al. (2014), and one literature review by Rippe 
and Angelopoulos (2014). The expert opinion by Drakopoulou et al. (2016) summarized the 
current recommendations for the lipid profile management of patients with CAD to present 
behavior modifications and medical treatment, applying the guidelines established by the 
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ACC/AHA and European Society of Cardiology. These implications are for the lifestyle and 
treatment of patients with CAD. The major focuses of this expert opinion included lipid levels, 
blood pressure, behavioral and psychosocial risk factors, smoking cessation, and body weight 
control. Overall improvements suggested increasing vegetable, fiber, whole grains, low-fat dairy, 
poultry, legumes, fish, and nuts for dietary modification. Incorporating daily physical activity was 
also advised to reduce LDL-C levels by 3-6 mg/dL when performed for 24 weeks in duration 
(greater than three days per week for forty minutes each session). A second lipid panel should 
be collected at 4-12 weeks after initiating statin therapy or if there is a change in lifestyle to 
further determine patient’s adherence (then performed every 3-12 months). These implications 
for practice support the impact of a lifestyle modification intervention on patients with CAD. By 
implementing dietary and physical activity changes, the risk for a major CV event can be 
significantly reduced by monitoring lipid panels and blood pressures. 
 In the expert panel by Eckel et al. (2014) from the ACC/AHA consisted of sixteen 
members in the Expert Work Group to develop a guideline based on high-level RCTs, 
observational studies, systematic reviews with meta-analysis. The purpose of this guideline is to 
“prevent CVDs, improve management of people who have these disease through professional 
education and research; and develop guidelines and standards and policies that promote 
optimal patient care and CV health” (Eckel et al., 2014, p. 2961). These guidelines aim to reflect 
outcomes of total cholesterol, LDL-C, blood pressure, levels of physical activity, and dietary 
habits and emphasized the focus on low-fat dietary patterns, which includes a decrease in fats 
(macronutrient) by following a DASH or Mediterranean diet. The guidelines also list ten lifestyle 
recommendations that support the need for tailored interventions as there is an inverse 
relationship between levels of physical activity and rates of CVD and beneficial effects on lipids, 
cholesterol, and blood pressure.  
 Another ACC/AHA guideline widely used in the clinical setting is by Stone et al. (2014) 
expert panel. This panel consisted of sixteen members that reviewed systematic evidence of 
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RCTs and systematic reviews with meta-analysis of RCTs. This guideline is intended to guide 
the treat adults, 21 and older, to complement the NHLBI CV health risk reduction guidelines. 
Thus, the major aim of this guideline on the treatment of blood cholesterol to reduce CV risk in 
adults is to monitor and treat blood cholesterol. Once again, Stone et al. (2014) emphasized that 
lifestyle is the foundation for ASCVD risk factors and should be continuously discussed with 
patients, but moreover, the recommended guideline focuses on four major statin benefit groups 
and does not recommend any specific LDL-C target goal. In secondary prevention, a high 
intensity statin medication provides the most benefit for patients less than or equal to 75 years 
of age. The care for the patient with CAD and hyperlipidemia should be individualized and 
clinical judgment should be based on experience and health status for target LDL-C goals. 
 The last piece of evidence is a literature review over the guidelines by Rippe and 
Angelopoulos (2014). Rippe and Angelopoulos (2014) summarized a recent review on how 
specific lifestyle strategies could be implemented to lower risk of CV disease based on the AHA 
Strategic Plan for 2020. This review discussed BMI and weight, amount of physical activity per 
week, blood pressure, dietary patterns, and smoking habits. Overall, patient counseling 
contributed a modest or sustained weight loss and should be utilized to achieve meaningful 
health benefits. In regards to dietary patterns, DASH dietary adherence improves overall CV 
health and should be recommended in the clinical setting. Patients should participate in 
moderate to intense aerobic and resistance training physical activity at 3-4 sessions (40 minutes 
per session). This review also reiterated a discontinuance of targeted treatment for goals for 
LDL-C therapy and instead reinforces the four major statin benefit groups, which is found in the 
original 2014 ACC/AHA guidelines by Stone et al. (2014). Rippe and Angelopoulos (2014) also 
reiterate the Eighth Joint National Committee (JNC 8) recommendations for lifestyle blood 
pressure regulation. These recommendations include regular aerobic exercise, limiting salt 
intake, maintain a healthy body weight, and smoking cessation. This article incorporates the 
ACC/AHA and JNC 8 guideline support to continue reinforcing lifestyle modifications for CAD 
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patients ready to make a behavioral change and provides rationale for implementing a lifestyle 
intervention focusing on improving CAD health.  
Construction of Evidence-based Practice  
 The construction of EBP was based on the synthesis of the appraised literature, then 
developed into a best practice model.  
Synthesis of Critically Appraised Literature 
 The literary evidence was synthesized to address the targeted population, emerging 
implications for practice, measurable outcomes, and duration of interventions. The age of the 
population in the literature focused on adults over age 18 (Cole et al., 2011; Hooper et al., 2015; 
Kotseva et al., 2016; Rees et al., 2013; van den Wijngaart et al., 2015). Others focused on 
adults ages 21 and over, age 28 or older, or age 30 and over (Noe et al., 2014; Stone et al., 
2014; Stuart et al., 2013).  
Al Mheid et al. (2016), Noe et al. (2014), Rees et al. (2013), Stuart et al. (2013), and Tapsell & 
Neale (2016) included healthy adult cohorts that were at risk for developing CAD (primary 
prevention). Cole et al. (2011), de Waure et al. (2013), Hooper et al. (2015), Kotseva et al. 
(2016), Salehi-Abargouei et al. (2013), and van den Wijbgaart et al. (2015) included adults with 
an established CAD diagnosis (secondary prevention). Primary prevention is applied to the 
intended population due to the effectiveness of interventions on healthy adults.  
 Implications for best practice are lifestyle modification programs for a health behavior 
change. Counseling is a necessary facilitator to include advice giving and providing patients with 
evidence-based resources, such as handouts, sample menus, and heart healthy recipes (Al 
Mheid et al., 2016; Cole et al., 2011; de Waure et al., 2013; Eckel et al., 2014; Hooper et al., 
2015; Kotseva et al., 2016; Rees et al., 2013; Ripper & Angelopoulos, 2014; Stone et al., 2014; 
Stuart et al., 2013, Tapsell & Neale, 2015). As a part of this intervention, it is strongly 
recommended that the counseling intervention and resource handout be individualized to 
patient preferences with a multifactorial and interdisciplinary approach incorporating dietary 
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changes and physical activity. Physical activity recommendation consists of three to four 
sessions per week at forty minutes per session, according to the 2014 ACC/AHA national 
guidelines (Al Mheid et al., 2016; Drakopoulou et al., 2016; Eckel et al., 2014; Noe et al., 2014; 
Rippe & Angelopoulos, 2014). A DASH-style or modified fat diet must be followed to lower CV 
risk factors with support from the AHA (Drakopoulou et al., 2016; Eckel et al., 2014; Hooper et 
al., 2015; Rees et al., 2013; Rippe & Angelopoulos, 2014; Salehi- Abargouei et al., 2013; van 
den Wijngaart et al., 2015). Self-efficacy and self-management skills were evaluated to observe 
the impact on long-term behavior changes (Cole et al., 2011; de Waure et al., 2013). To make 
these lifestyle modifications a success, close engagement with healthcare providers is essential, 
especially if providers follow the 2014 ACC/AHA guidelines; counseling can be achieved 
through face-to-face, handouts, and/or telephone support (Al Mheid et al., 2016; Cole et al., 
2011; de Waure et al., 2013; Drakopoulou et al., 2016; Eckel et al., 2014; Noe et al., 2014; 
Rippe & Angelopoulos, 2014; Stone et al., 2014; Stuart et al., 2013; Tapsell & Neale, 2015; van 
den Wijngaart et al., 2015). 
 Anthropometric outcomes were used to objectively measure adherence and effects of 
CV biomarkers. These outcomes consist of measuring weight and height to calculate BMI. The 
literature measured primary and secondary outcomes at baseline and throughout the duration of 
the studies. Lipid panel and blood pressure were ordered to evaluate total cholesterol, LDL-C, 
and/or HDL-C (Al Mheid et al., 2016; Cole et al., 2011; Drakopoulous et al., 2016; Eckel et al., 
2014; Hooper et al., 2015; Kotseva et al., 2016; Noe et al., 2014; Rees et al., 2013; Stone et al., 
2014; Stuart et al., 2013; Tapsell & Neale, 2016; van den Wijngaart et al., 2015). Other 
measurements that affect CV risk included in the studies were waist circumference, BMI, dietary 
habits, and physical activity (Al Mheid et al., 2016; Cole et al., 2011; Eckel et al., 2014; Hooper 
et al., 2015; Kotseva et al., 2016; Noe et al., 2014; Rees et al., 2013; Rippe & Angelopoulos, 
2014; Salehi-Abargousei et al., 2013; Stuart et al., 2013; Tapsell & Neale, 2016; van den 
Wijngaart et al., 2015). CV events or incidence were also included as primary or secondary 
LIFESTYLE MODIFICATION PROGRAM  
  
 
35 
outcomes in which fatal or nonfatal events were considered significant findings (Cole et al., 
2011; de Waure et al., 2013; Hooper et al., 2015; Salehi-Abargouei et al., 2013). As a result of a 
lifestyle counseling and modification program, anthropometric biomarkers, BMI, dietary habits, 
physical activity, and CV events showed clinically significant improvements.  
Best Practice Model Recommendation 
 The best practice model recommendation for this EBP project targets adults ages 18 
and older with coronary artery disease and hyperlipidemia to focus on secondary prevention in 
the clinical setting for optimal risk reduction for a secondary fatal or nonfatal coronary event. A 
lifestyle modification program, that consists of a brief, yet effective counseling session focusing 
on multifactorial lifestyle changes for health promotion with a complementary resource tool, was 
implemented to lower secondary CV event over six months. The intervention was administered 
by the project manager who will continually monitor patient progress. Face-to-face and 
telephone modalities was used to deliver the intervention and follow up patients during this 
project. The participant handout was consisted of expanding on the knowledge and awareness 
of health; then, a discussion regarding personal risk factors will occur to promote patient-
centered care, and a handout will be distributed to promote a heart healthy lifestyle that is 
supported by the AHA. An introduction regarding the meaning of lipid panel values and effect on 
health was initiated and what certain foods, low in saturated fat, and exercise can do to promote 
CV health. Dietary, physical activity guidelines and DASH-style diet will be included, as 
mentioned in the supportive literature. Participants were also required to complete the Rate-
Your-Plate for Blood Cholesterol tool (Gans, Hixson, Eaton, & Lasater, 2000) and the Rapid 
Assessment of Physical Activity (RAPA) (University of Washington, 2006) evaluate their dietary 
and physical activity habits. Primary and secondary outcomes were measured at baseline and 
six months; the primary outcome being measured was a baseline and follow up lipid panel for 
LDL-C, and the secondary outcomes being measured are blood pressure, BMI, dietary habits, 
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and physical activity. Findings were then analyzed from the participant’s lab values and changes 
from dietary and physical activity recommendations.  
How the Best Practice Model Will Answer the Clinical Question 
 This best practice model answered the clinical question by addressing the clinical 
problem of a cost-effective, time-efficient, patient-centered intervention to reduce hyperlipidemia 
in CAD adult patients. It is recommended in the guidelines that lifestyle changes should be a 
major focus to changing the status of cardiac risk, however, not all providers have extensive 
time to do this. If a patient-centered handout was developed to assist the patient toward making 
these changes, there might be clinical benefit of using it in long-term clinical practice. Therefore, 
this lifestyle modification program will include a brief counseling session and patient-centered 
handout. The counseling session will include the meaning and impact of cholesterol on cardiac 
health and then, dietary and physical activity recommendations will be reviewed in the table of 
contents of the handout. 
CHAPTER 3 
IMPLEMENTATION OF PRACTICE CHANGE  
The implemented practice change occurred over six months and was a facilitated health 
behavior change. By promoting cardiovascular health for adult patients with coronary artery 
disease, a patient-guided resource, paired with face to face counseling, provided participants 
with basic yet vital information for improving health practices. The resource also included a 
patient-specific component at the end of each section to allow participants to reflect on their 
self-efficacy and status of behavior change. The overall goals of this EBP implementation is to 
lower secondary risk for nonfatal and fatal cardiac events for adult patients with coronary artery 
disease.  
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Participants and Setting 
 The participants for this EBP project were adult patients with an established coronary 
artery disease diagnosis. The implementation of this EBP project took place at a local 
cardiology outpatient practice affiliated with a not-for-profit with a diverse patient population. A 
manual review of the patients’ electronic health records, determined which patients met the 
inclusion criteria. Inclusion criteria included the following qualifications: adults ages eighteen 
and older, previously established CAD diagnosis, hyperlipidemia diagnosis, ability to perform 
physical activity, and access to a phone and internet resources. Participants were excluded 
from this study if they are children, under the age of eighteen, pregnant or breastfeeding, living 
with cognitive impairment or delays, unable to exercise, following strict diets, living with an 
eating disorder, and/or receiving dialysis treatment. Once patients met the inclusion criteria, 
either the nurse practitioner or the cardiologist verbally discussed the purpose of the project and 
eligibility with the patient for recruitment. If the patient was agreeable, then he or she met with 
the project manager to further discuss the project, sign the informed consent, and receive the 
lifestyle counseling portion of the intervention. Participants were recruited in September 2018, 
pre-intervention measurements taken at baseline and at six months. 
Outcomes 
 The primary outcome of the project was the LDL-C (mg/dL) drawn from a fasting lipid 
panel. Secondary outcomes that were measured include blood pressure (mmHg), BMI (kg/m2), 
dietary habits, and physical activity assessment. Dietary habits were assessed by instructing the 
participant in how to fill out the patient-focused pre- and post- intervention tool. The RYP for 
Blood Cholesterol scores was based on dietary choices ranging from 23 to 69. Scores were 
tallied by patient’s selection of dietary choices. Ranges 23-38 indicate there were many ways to 
make healthier dietary choices, a score within the range of 39-54 mean there were a few ways 
to make healthier dietary choices, and a score of 55-69 verified healthy dietary choices are 
being made.  
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The RAPA tool is a quick assessment in which providers can quickly assess physical activity 
and has two categories, aerobic activity and strength and flexibility. A score of 1 refers a 
sedentary lifestyle, score of 2 is an under-active patient, score of 3 is being under-active to 
lightly active, scores 4 and 5 regularly exercises but is underactive, and scores of 6 and 7 are 
active. Fore strength and flexibility, participants who perform activities to increase muscle 
strength receive a score of 1, and if a participant does regular stretching and/or yoga activities, 
they receive a score of 2. A score of 3 is given if a participant both performs strength and 
stretching activities. Outcome data was compared to each other at baseline and 6 months post 
intervention. These outcomes were helpful to determine the indications to continue this practice.  
Intervention 
 The intervention for this EBP project was a multifactorial strategy to promote lifestyle 
management in coronary artery disease patients with CAD. The intervention included measuring 
participant’s LDL-C, blood pressure, BMI, RYP for Blood Cholesterol Tool score (Appendix B), 
and RAPA (Appendix C) score significance at baseline and 6 months. Clinical significance was 
important to determine if this practice helped lower LDL-C levels and encouraged patients to 
maintain a heart healthy lifestyle. The intervention also included an individualized counseling 
session, following the guidelines set forth by the ACC/AHA. In this counseling session, the 
project manager and participant reviewed the benefits and risk of participation, expected follow-
up, follow-up appointment, and review of baseline LDL-C, blood pressure, and BMI. Participants 
also completed the Rate-Your-Plate Tool for Blood Cholesterol (Gans et al., 2000) questionnaire 
for dietary habit assessment and the RAPA (Topolski et al., 2006) for physical activity pattern.  
 The participants then received a self-guided patient booklet that contains a health profile 
record, dietary and physical activity guidance, and stress management relief techniques, used 
with permission from the AHA and NIH. Participants were instructed to complete each section 
every week and complete the self-guided patient component. The self-guided component was 
intended to increase patient knowledge and self-efficacy to build lifelong learning and disease 
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management skills. A telephone call follow-up was initiated the first week post intervention, and 
monthly, thereafter. The telephone follow-up was intended to assess participant perspective on 
the current status of the intervention and remind patient to stay on track with the sections of the 
booklet. Participants were expected to obtain their follow-up LDL-C sample prior to their 6-
month follow-up office appointments. The 6-month follow-up appointments involved meeting 
with the healthcare provider to review lab work and then meeting with the project manager to 
review completed portions of the patient booklet, answer any questions, and complete the Rate-
Your-Plate Tool for Blood Cholesterol (Gans et al., 2000) for dietary assessment and the RAPA 
tool for the level of physical activity completed (Topolski et al., 2006). Data was updated as 
received by participants and analyzed after the 6-month follow-up.  
Planning 
 This EBP project was a result of a clinical problem discovered during clinical rotations. 
The clinical problem was the observation of patient disconnect from their LDL-C levels and 
knowledge of a heart healthy lifestyle. A literature search was performed to determine a best 
practice strategy to improve the health of patients with CAD and hyperlipidemia. The Health 
Promotion model was used to guide best practice for a lifestyle modification intervention. Project 
site was selected based on the patient population and need for advanced practice nursing 
intervention. Permission was obtained from facilitators at the project site to conduct the project 
and collect data. Site facilitators were kept updated during this process.  
 Once IRB approval was received, patients were recruited based on the inclusion and 
exclusion criteria. The electronic medical records of patients with upcoming appoints during the 
recruitment period were reviewed. Site facilitators were notified ahead of time who qualified for 
the project, so they could verbally convey project details to the convenience sample of potential 
participants. Once the patient agrees to participate in the EBP project was initiated based on 
strategies listed as the intervention. The implementation involved all aspects of the clinical site 
including the health care providers and the office medical assistant, who obtained vital 
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measurements. Intervention was directly implemented by the project manager who will also 
perform follow-up telephone calls and the 6-month follow-up assessments.  
Data 
Measures 
 The data measured in this EBP project will be a LDL-C, blood pressure, BMI, dietary, 
and physical activity patterns. A 12- hour lipid panel was drawn. To ensure blood pressure, 
weight, and height is valid, project manager ensured medical assistant took patient 
measurements with the appropriate technique each time. Blood pressure were measured with 
the patient in the sitting position, legs uncrossed, feet planted on the floor, arm upward in 
pronation resting at chest level on a solid surface, and with the same blood pressure machine 
each time (standard technique). Height was measured with the device, and weight was taken on 
the same scale, zeroed for weight accuracy. The tools used to collect these measurements 
were the same during each collection for each participant.  
 Dietary and physical activity assessment tools were used to evaluate dietary patterns 
and physical activity levels. The dietary assessment tool utilized in this EBP project was the 
Rate-Your-Plate Tool for Blood Cholesterol (Gans et al., 2000). This tool was studied and 
shown to be both valid and reliable. Physical activity assessment was evaluated using the 
RAPA tool (Topolski et al., 2006). This tool is easily accessible for healthcare providers and 
patients and is a valid form of measuring physical activity in the clinical setting.  
Collection 
 To collect data, participant privacy was a priority objective. Data was coded by using a 
random assignment of numbers. Data was collected by venous sampling for fasting lipid profile 
to read LDL-C levels. Anthropometric data was collected by office personnel and data typed into 
electronic record for project manager viewing and use. The Rate-Your-Plate Tool for Blood 
Cholesterol (Gans et al., 2000) and RAPA survey were collected by project manager in paper 
and pencil format that will contain the patient’s randomly assigned number on the upper right-
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hand corner to correlate with patient identification that was followed throughout the duration of 
the project. During the duration of the project, data was recorded in a flowsheet and kept secure 
in a password protected computer. The data was inserted into a statistics software program 
(SPSS) for statistical analysis.  
Management and Analysis 
 The management of patient data was in the form of paper and online data recording. 
Data collected from participants were kept on site unless needed for input analysis; data was 
inserted into the latest version of SPSS software to determine the significance of the 
intervention. 
Participant data was protected in a lockbox in which the project manager was the only one who 
has the code and key. Information was stored at project site in a locked filing system behind 
locked doors after hours unless needed for input into SPSS version 25 software or further 
analysis. The participant data was analyzed by collecting final results of participant LDL-C, 
blood pressure, and BMI. Pre- and post- intervention results will be compared using paired t-
tests to determine clinical significance. Dietary scores results will be compared pre- and post- 
intervention using paired t-tests, as well. Physical activity assessment will be assessed using 
the scores from the RAPA tool (Topolski et al., 2006). Data will be analyzed by comparing pre- 
and post- intervention scores using paired t-test. 
 Descriptive statistics were used for demographic data collected during this EBP project. 
Chi-Square test will be used to analyze differences between groups. Demographics collected 
were gender, marital status, identifiable race/ethnicity, income, highest level of education 
medication use, and years diagnosed with CAD This data was used to display differences 
among demographic groups.  
Protection of Human Subjects 
 To protect participants from unethical behavior and unnecessary harm, IRB approval 
was obtained from both the educational and professional institutions where the project took 
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place. Prior to IRB approval, project manager was able to gain clinical site permission and a 
documentation of approval for EBP project.  This project contained a level of risk that is minimal 
and provided full disclosure of project intent to IRB and future participants, falling under an 
expedited review from both IRBs.  
CHAPTER 4 
FINDINGS 
This evidence-based practice project focused on the reduction of lipid levels in adult 
patients with CAD. These patients were counseled regarding lifestyle changes according to the 
ACC/AHA guidelines. A lifestyle modification intervention was designed based on best practice 
found in an extensive literature search. After completion of the implementation phase, the 
findings were analyzed. The following analysis describes the demographics and outcomes of 
the intervention. 
Participants 
 The participants were recruited from September 2018 and were followed up in January 
and February 2019 at a local northwest Indiana cardiology practice. A total of 14 patients 
participated for the full six months. There was no attrition throughout the duration of the project. 
The purpose of this project was to determine the impact of a patient-led lifestyle modification 
intervention for adult patients with CAD.  
 The 14 participants were followed over a 6-month time period, after the initial counseling 
session, with monthly phone call follow-ups to monitor for adherence to the lifestyle modification 
intervention. Primary and secondary outcomes were measured pre-intervention and six months 
post-intervention. There was no attrition; all fourteen participants completed the study as 
instructed, possibly due to the close follow-ups and ease of contacting the project manager.  
Characteristics 
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 The participant demographic characteristics were gender, marital status, race/ethnicity, 
annual household income, highest level of education completed, taking a medication to lower 
cholesterol/lipids, years diagnosed with CAD, and range of ages. Based on the demographic 
data form completed by the participant, the information was placed into SPSS version 25 for 
frequency and mean analysis. Of the recruited participants (N = 14), 85.7% (n = 12) were male, 
and 78.6% (n = 11) were married (see Figure 4.1). The rest of the participants (n = 3) were 
either single (n = 1) or widowed (n = 2); no one selected divorced. In regards to race ethnicity, 
92.9% (n = 13) of participants identified as white or Caucasian, and the remaining participant  
(n = 1) identified as black or African American. Household income was placed into range groups 
that varied from less than $50,000, $51,000 - $75,999, $76,000 - $100,999, $101,000 - 
$150,999, greater than $151,00, or preferred not to answer. Figure 4.2 depicts the ranges of 
household income. A cumulative 57.1% (n = 8) made either less than $50,999 (n = 4) or 
$51,000 - $75,999 (n = 4).  
 The highest level of education completed was high school diploma or equivalent, which 
consisted of 42.9% (n = 6) of participants. 21.4% (n = 3) had a technical or vocational degree, 
14.3% (n = 2) had associate’s degrees, and 21.4% (n = 3) has a master’s degree. TAll (n = 14) 
participants were prescribed statin-lowering pharmacological therapy. The length of CAD 
diagnosis was listed in year range groups; 71.4 % (n = 10) of the participants have been 
diagnosed for greater than 10 years. The other participants (n = 4) have been living with CAD 
for 5 – 10 years (n = 3) or less than 6 months (n = 1). The participants then selected their age 
range on the demographic questionnaire. Age ranges included 18 – 29 years, 30 – 40 years, 
41- 50 years, 51- 60 years, 61 – 70 years, 71-80 years, 81- 90 years, and 91 years and older. 
Figure 4.3 displays the frequency of the age distribution; the majority, 42.9% (n = 6), of 
participants were between ages 61 – 70 years. Table 4.1 and 4.2 demonstrate the overall 
participant demographic characteristics and pre-intervention means for primary and secondary 
outcomes. 
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Figure 4.1 
MARITAL STATUS 
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Figure 4.2 
HOUSEHOLD INCOME 
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Figure 4.3 
AGE RANGE 
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Table 4.1 
Participant Characteristics  
      Frequency   
Characteristic       n (%)        
 
Gender   
   Male      12 (85.7)  
   Female       2 (14.3) 
Marital Status 
   Single       1 (7.1) 
   Married     11 (78.6) 
   Widowed       2 (14.3) 
Race/Ethnicity          
  White      13 (92.9) 
   Black        1 (7.1) 
Annual household income 
    < $50,999        4 (28.6) 
    $51,000 - 75,999      4 (28.6) 
    $76,000 – 100,999      1 (7.1) 
    $101,000- 150,999      2 (14.3) 
    $151,000 >                  1 (7.1) 
    Prefer not to answer    2 (14.3) 
Highest level of education completed 
   High school diploma     6 (42.9) 
   Technical/Vocational    3 (21.4) 
   Associate’s degree      2 (14.3)       (continued) 
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Table 4.1 
Participant Characteristics (continued) 
   Frequency   
Characteristic       n (%)    
 
Highest level of education completed 
   High school diploma     6 (42.9) 
   Technical/Vocational    3 (21.4) 
   Associate’s degree      2 (14.3) 
   Master’s degree            3 (21.4)      
Years with CAD 
     < 6 months     1 (7.1) 
     5-10 years     3 (21.4) 
     > 10 years     10 (71.4) 
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Table 4.2 
Primary and Secondary Outcomes 
  Pre-Intervention              Post-Intervention 
Outcome  M (SD)    M (SD) 
 
LDL-C  67 (20.78)   62 (16.11) 
BMI  33.33 (5.74)   29.74 (4.06) 
BP           
   Systolic 133 (15.21)   132 (22.21) 
   Diastolic 78 (9.50)   76 (8.75)    
RAPA 1 4 (1.83)   5 (0.94) 
RAPA 2 0.5 (1.09)   2 (0.92) 
RYP for  48 (6.8)   58 (4.58) 
Blood Cholesterol     
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Changes in Outcomes 
  The primary outcome analyzed was the pre- and post- intervention LDL-C levels. 
Secondary outcomes examined were: BMI, BP, RYP for Blood Cholesterol scores, and RAPA 
scores. The data were analyzed to identify any relationship between the demographic 
characteristics on primary and secondary outcomes using a Chi Square with a statistical 
significance level of p <.05  
Statistical Testing 
 The statistical method used for identifying possible correlations on LDL-C levels, BP, 
BMI, dietary choices, and physical activity was the paired samples. For the pre- and post- 
intervention data, a paired- samples t - test was performed to analyze for clinical significance. 
Demographic characteristics were measured on either a nominal or ordinal level, based on the 
type of data collected. LDL-C was measured based on interval-level data, as well as the mean 
score for secondary outcomes, BMI, BP, RYP for Blood Cholesterol score, and RAPA score.  
Table 4.2 displays data for pre- and post-intervention outcomes. Figure 4.4 compare pre-
intervention and post-intervention LDL-C levels, and Figure 4.5 and 4.6, respectively, compare 
pre-intervention and post-intervention RYP for Blood Cholesterol and RAPA scores.  
Primary outcome  
 The primary outcome of this EBP project was a comparison of participant’s LDL-C pre- 
and post- intervention. and A side by-side histogram (Figure 4.4) demonstrates the 
comparison between pre- and post- intervention information. The mean pre-intervention data 
was 67 mg/dL (SD = 20.78), and the post-intervention mean was 62 mg (SD = 16.11). The 
significance of the intervention was determined by running a paired t-test. The paired t- test 
revealed t (13)= .759, p<.05 95% CI [-8.97, 18.68] and significance level of 
.461, which is not clinically significant (see Table 4.3).  
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Figure 4.4 
PRE- AND POST-INTERVENTION LDL-C LEVELS 
  Pre-intervention LDL-C     Post-intervention LDL-C 
            
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Secondary outcomes 
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 The secondary outcomes measured in this EBP project were BP, BMI, dietary habits, 
and amount of physical activity. The means for these secondary outcomes are listed above in 
Table 4.3. Results for significance were based on the collected post-intervention significance of 
the paired t-tests.  SBP (t(13)= .056, p<.05 95% CI [-13.33, 14.05]) and DBP (t(13)= .886, p<.05 
95% CI [-3.39, 8.11]) with clinical significance levels of .956 and .392, respectively, which is not 
considered to be clinically significant. For BMI, the results of the paired t-test were t(13)= 1.655, 
p<.05 95% CI [-1.00, 8.30] and significance level of .122 and is not clinically significant. 
 Dietary habits were measured by having participants fill out the RYP for Blood 
Cholesterol questionnaire. These scores were based on eating habits consistent with the 
ACC/AHA recommendations for heart healthy living. The pre-intervention mean score was 48 
(SD = 6.8), and the post-intervention score was 58 (SD = 4.58), also displayed in Figure 4.5. 
After running a paired samples t-test, the results concluded t(13)= -4.237, p<.05 95% CI [-15.10, 
-4.90] with a significance level of .001, which is considered clinically significant. For physical 
activity, participants were asked to complete the RAPA questionnaire, which has two sections. 
The first part of the RAPA questionnaire contained amount and type of physical activity, and the 
second part contained questions regarding strength training and flexibility. The mean pre-
intervention score for the first part was 4 (SD = 1.83) and a post-intervention mean was 5 (SD = 
0.94). A paired samples t-test was conducted which resulted a t(13)= 2.421, p<.05 95% CI [-
2.57, -.15] and a significance level of .031, which is significant. The second part of the RAPA 
tool pre-intervention mean was 0.5 (SD = 1.09) and a post-intervention mean of 2 (SD = 0.92). 
A paired t-test was showed significance, t(13)= -4.583, p<.05 95% CI [-2.21, -.79] with a 
significance level of .001. Participant results were significant for dietary and physical activity 
habits.   
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Figure 4.5 
DISTRIBUTION OF RYP FOR BLOOD CHOLESTEROL TOOL SCORES 
 Pre-Intervention RYP scores   Post-Intervention RYP scores 
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Figure 4.6 
DISTRIBUTION OF RAPA 1 AND 2 SCORES 
 Pre-Intervention RAPA 1 Scores  Post-Intervention RAPA 2 Scores 
  
  
 Pre-Intervention RAPA 2 Scores  Post-Intervention RAPA 2 Scores 
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Significance 
 Table 4.3 contains the complete display of the significance of primary and secondary 
outcomes. 
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Table 4.3 
Paired-Samples t-test Comparison for Primary and Secondary Outcomes 
             
       
Outcome    M (SD)  N df   Sig. (2-tailed) Std. Error Mean         
   
LDL     14 13  .461 
   Pre  66.57(20.78)       5.55   
   Post  61.71(16.11)       4.31 
SBP     14 13  .956   
    Pre  132(15.21)       4.07 
    Post  132(22.21)       5.94 
DBP     14 13  .392   
    Pre  77(9.50)       2.54 
    Post  75(8.75)       2.33 
BMI     14 13  .122  
    Pre  33.33(5.74)       1.53 
    Post  29.74(4.06)       1.08 
RYP     14 13  .001   
    Pre  48(6.80)       1.82  
    Post  58(4.58)       1.22 
RAPA1    14 13  .031 
    Pre   4(1.83)        .49 
    Post  5(.94)        .25 
RAPA2    14 13  .001   
    Pre  .5(1.09)       .29         
    Post  2 (.92)        .25 
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CHAPTER 5 
DISCUSSION 
 The purpose of this EBP project focused on the effectiveness of a lifestyle modification 
intervention that aids in pharmacological therapy (if applicable) to improve cholesterol levels in 
adults with coronary heart disease. The primary outcome of lowering LDL-C levels by a targeted 
lifestyle modification counseling session has been shown to lower cardiovascular risk, thus 
reducing patient’s risk for a major cardiac event. Secondary outcomes included measuring 
effects on blood pressure, body mass index (BMI), and dietary and physical activity changes. 
The results from the data were interpreted to explain and address the PICOT question and 
purpose of this EBP and relate findings to future implications in advanced nursing practice, 
theory, research, and education. 
Explanation of Findings 
Primary and Secondary Outcomes 
 The overall impact of the lifestyle intervention and counseling on LDL-C levels was 
insignificant (p= .461), as there was no significant difference in LDL-C pre- and post- 
intervention. This insignificant clinical finding may have been due to the fact that participants 
had a therapeutic LDL-C level prior to implementation and were prescribed a cholesterol-
lowering medication before the course of the implementation period. However, therapeutic LDL-
C levels were maintained throughout the duration and no cardiac events or deaths occurred. 
The majority of participants were between the ages of 61-70 (42.9%), all taking cholesterol 
lowering medications (100%), and were diagnosed with CAD and hyperlipidemia for ten years or 
more (71.4%). Inferences can be made that there is longevity with CAD and increased 
education exposure in correlation with medications, and interactions with health providers. 
LIFESTYLE MODIFICATION PROGRAM  
  
 
58 
 The secondary outcomes measured were SBP, DBP, BMI, dietary habits, and physical 
activity. SBP and DBP were not clinically significant in pre- and post- intervention blood 
pressure readings. (p= .956, p= .392), which remained consistent and unchanged. Although 
there appeared to be a decrease in overall BMI means pre- and post- intervention, there was no 
significance for clinical implications in the reduction of BMI.RYP for Blood Cholesterol tool 
results showed significance. There was an improvement in dietary choice scores after six 
months (M= 58, 4.58), suggesting lifestyle modification intervention impacted participants 
dietary choices. The RAPA tool, that assessed for physical activity levels, had a significant 
increase in the type and amount of both physical activity and strength and flexibility. The data 
did answer the PICOT question of lowering blood cholesterol in six months; it maintained levels, 
but pre-intervention levels were therapeutic. There was a reduction in risk factors associated 
with secondary cardiac events, as supported by the significance found in measuring secondary 
outcomes.  
 In the review of literature, the DASH diet or “heart healthy” diet lifestyles reported in 
Rees et al. (2013) which included a reduction of fat intake and healthy eating habits were 
consistent with the findings from this EBP project. Cole et al. (2011) systematic review, reported 
that an increase in physical activity would be observed post-lifestyle modification intervention. 
Self-efficacy and management of disease was mentioned in several studies and was one of the 
primary foci when developing this intervention. Participants cholesterol, blood pressure, and 
BMI remained stable, which reduces risk factors for secondary fatal cardiac events. Provider 
involvement with valid dietary and physical activity measurement tools improved participant self-
management outside the clinical setting. There were no major deviations of LDL-C levels in this 
project. There were updates for blood cholesterol management guidelines in 2018. Overall, the 
results from this EBP project was consistent with the current literature search using key search 
terms.  
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Evaluation of Applicability of Theoretical and EBP Frameworks 
Theoretical Framework 
 Pender’s Health Promotion model consists of four major interacting concepts which 
influence patient’s health promotion. Individual counseling sessions were implemented as part 
of the intervention to focus on patient dietary and physical activity preferences. Participants 
consented based on their desire to reach optimal cardiac health with the hope of improving 
current lifestyle choices for their future health. The APN role as leader, consultant, clinician, and 
educator ere emphasized to improve access to care for patients, meeting healthcare and 
personal goals. Leader role was fulfilled through leading the EBP project, and researching and 
planning the intervention, and conducting counseling sessions and follow-up. Health was 
optimized by utilizing the best appraised literature to connect relationship between patient and 
APN. A behavioral intervention was created based on interacting participant’s current state of 
health with self-efficacy perception. Compliance and effectiveness was determined by 
maintenance or improvement in LDL-C measurements.  
 Environment impacts participant healthcare decisions based on culture, socioeconomics, 
preferences, and access. The context affects the overall schema of participants view of health 
and feelings regarding a self-led. During each counseling session, the concept of environment 
was discussed to promote interest and personal impact of a heart healthy lifestyle and access to 
preferences for resources, such as grocery store locations, restaurant menus, physical 
activities, recipes, online support, and smartphone applications. The APN role promotes overall 
national healthcare goals consistent with guidelines recommendations by implementing this type 
of intervention.  
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 This health promotion theory was appropriate for this EBP project based on the 
incorporation of the nursing metaparadigm with the main goals of improving health outcomes 
and quality of life by decreasing the incidence of secondary cardiac death. Barriers to success 
were addressed early in the implementation phase to create a plan of action when participants 
discussed their vulnerabilities and lack of knowledge. A plan of action was prepared during the 
counseling sessions for grocery shopping and eating out. This concept incorporated Pender’s 
self-efficacy and health promotion initiation to overcome perceived barriers to action. 
Interpersonal influences played an important role in the implementation and evaluation phase 
due to the impact participant’s spouses, children, and friends. They encouraged health 
promotion for participants and held participants accountable for committing to the plan of action, 
as Pender suggested participants are more willing to follow through with the intervention with 
the influence of a support system.  
 Strengths of Pender’s Health Promotion model are the concepts and application of 
health promoting behavior within the nursing metaparadigm. The lifestyle modification program 
was created within the context of nursing. The theory supports the purpose of this EBP project 
to assist APNs with introducing and influencing health promoting behaviors based on literary 
evidence. Preparation for working with participants with little or no self-efficacy skills and 
understanding how to approach these patients with a treatment plan was guided by the Health 
Promotion model. The main objectives focused on goal-setting; the project was six months in 
duration in which small goals were implemented in the patient-guided booklet to meet the larger 
overall goal of lowering or maintaining a therapeutic LDL-C level and healthy lifestyle choices. 
 Weaknesses of Pender’s Health Promotion model include the efforts of individualizing 
treatment plans and how to guide patients of different cultural and socioeconomic backgrounds. 
The majority of participants in this project were white, older adult males. Also, the complexity of 
increasing participant access to resources and maintaining healthy lifestyles was difficult to 
individualize based on participant’s geographical location. Participants may grow weary or 
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complacent once they obtain a therapeutic LDL-C level and may not notice a difference in pre- 
and post- intervention behaviors. Bias occurs when an APN has personal choices that differ 
from participants and may lead to a barrier. The Health Promotion model is patient-focused. For 
example, choosing to participate in certain types of diets, fitness programs, and social media 
sites is a personal preference and APNs must recognize their own preferences may differ from 
patient preferences. The intervention was individualized, and therefore, time consuming due to 
the complexity of considering participant appointment times, journaling during personal time, 
and discussing status on the telephone. Overall, the Health Promotion model is an appropriate 
nursing theory for this health-promoting nursing intervention.  
EBP Framework 
 Stetler’s model for Research Utilization help guided the EBP process. The five phases of 
this model include preparation, validation, decision-making, translation, and evaluation. This 
model was an adequate fit for this EBP project based on the clinical need for lifestyle 
modification guidance and motivation, which is first-line treatment, according to the ACC/AHA 
guidelines. The literature search validated the need and effectiveness of lifestyle and healthcare 
support. Also, relaying the information to participants in a relatable format appealed to their level 
of knowledge and understanding, considering environmental factors. Goals were set based on 
participant response to best practice recommendations. A final evaluation collectively assessed 
objective and subjective findings from data collection for future practice. 
 The strengths and limitations of this EBP model included incorporating all five stages 
from research utilization as a result of the literature review to an EBP intervention. The plan of 
action was as step-by-step process that needed constant decision-making and translating into 
nursing implications. Limitations included the inability to apply every assumption to the 
participant’s situation. This project was the initial application of this EBP model by the project 
manager and appropriate use could be a limitation. Modifications were made to simplify the 
process to ease into the application of EBP. Although there were no major modifications, they 
LIFESTYLE MODIFICATION PROGRAM  
  
 
62 
involved taking a more subjective approach to relate the context of the material to achieve 
targeted outcomes. The translation of research was based on a review of the literature and 
implementing applicable interventions to patient population that included a validation of the 
problem, after synthesizing the appraised literature.  
Strengths and Limitations of the EBP Project 
 The strengths and weaknesses of this EBP project include what the outcomes implied, 
such as medications are effective, and there is clinical significance for behavior changes toward 
a heart healthy lifestyle, as validated through the initial literature search. Clinical use is practical, 
increasing participant access to resources, cost-effective, and time efficient. This EBP project 
applied national recommended guidelines as part of the literary synthesis into a translatable 
intervention. The counseling portion took ten minutes to complete with the participant and 
included focusing on each participant’s current lifestyle and preferences. Telephone calls 
monitored participant progress and adherence to the lifestyle modification booklet. This booklet 
was reviewed at the six-month follow-up. Participant’s growth of knowledge was evident through 
verbalizing understanding of the material and applying the principles in their self-guided booklet. 
By applying principles learned through the self-guided booklet, participants can be self-
efficacious. Participants had completed the intervention which is supported by the significance 
of the RYP for Blood Cholesterol tool and RAPA tool post-intervention scores. Overall, this EBP 
project is patient-focused and provide means for lifestyle improvements without spending an 
entire healthcare visit discussing lifestyle. This EBP project also supports self-learning and self-
efficacy, based on the absence of attrition and completion of the self-guided booklet. Progress 
can be measured through validated tools and evidence-based research that utilize nursing 
theories and goals.  
 Weaknesses include: the overall sample size was small, which may influence the effect 
size and applicability in larger samples, the participant population lacked diversity, so it is 
unclear whether or not this intervention would be appropriate for various races/ethnicities, 
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socioeconomic, marital, and/or gender groups. Participants had therapeutic LDL-C levels prior 
to intervention, and there were no major changes in this post-intervention, so there was no 
clinical significance regarding the reduction of LDL-C levels. This lifestyle modification 
intervention may be more effective on patients who are at higher ASCVD risk and uncontrolled 
cholesterol levels. The paper booklet may also be burdensome to some patients. Application of 
this EBP project may vary in the future based on technological advances through smartphone 
and computer usage.  
Implications for the Future  
Practice 
 Implications for advanced nursing practice are for the role of the family nurse practitioner 
as clinician and consultant. By enforcing EBP and national guideline recommendations, 
conclusions can be made to tailor a patient-centered counseling session and intervention to 
improve clinical outcomes. The family nurse practitioner must consider the patient’s 
environmental context in which health is maintained to assist in locating resources and support. 
These environmental factors include patient’s culture, society, economics, and technology. The 
FNP should act as change agents to modify current lifestyles. These environmental factors 
impact patients in regard to their incomes, dietary budgets, physical limitations, access to 
resources, computer and internet familiarity. The family nurse practitioner is a leader in regard 
to change by initiating new ideas that are relevant in literature. Taking time to discuss patient’s 
environment and self-efficacy toward health maintenance fulfills organizational goals to reduce 
health disparities and costs of secondary cardiac events. These implications are applicable to all 
three levels of prevention.  
 The lifestyle modification program can be applied to primary, secondary, and tertiary 
levels of prevention for cardiac health. Primary prevention starts with preventing primary cardiac 
events and promoting healthy lifestyles starting in adolescence and young adulthood through 
education curriculums and well child visits. Secondary prevention occurs in patient follow-ups 
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involving both the family nurse practitioner and the patient. The family nurse practitioner’s role 
as clinician is to screen those with pertinent cardiac family history or ASCVD risk factors. 
Tertiary prevention was implemented through this EBP project for those who had an initial 
cardiac event and needed guidance to prevent a secondary cardiac event.  
Theory 
 Pender’s Health Promotion model was an applicable nursing theory to assist the APN to 
promote cardiac health in patients with established CAD. There is also a self-care deficit in 
those patients who do not practice healthy lifestyles. Dorothy Orem’s Self-Care Deficit theory 
which assesses a patient’s ability to care for self, and when there is a self-care deficit or patients 
are “incapable of or limited in their ability to provide continuous effective care”, nurses need to 
intervene (George, 2011, p. 117). Her theory could also be applied to this EBP project. Orem 
explains five methods of helping that are relevant in health promoting interventions. They are 
acting and doing for another, guiding and directing, providing physical or psychological support, 
environmental support, and teaching. Educating patients must be relatable to their level of 
knowledge and comprehension. This EBP project focused on patients with established CAD, 
and the age group of the participant population consisted of mostly older adults, who preferred 
writing on paper over typing on a computer. The learning material was taken from professional 
literature, but created into a context that was understandable and relatable to the intended 
population. Guiding and directing patients should be based on setting mutual goals, such as 
reaching targeted LDL-C levels, making healthier dietary choices, and incorporating a physical 
activity into their day, even small ones. This guidance should be focused on moving the patient 
toward maintaining wellness on the healthcare continuum. 
 Furthermore, providing physical and psychological support was an essential component 
for the desired outcomes and purpose of this EBP project. Connection should be kept open 
between healthcare provider/project manager. This connection was achieved by reaching out to 
participants during the implementation and monitoring phases through telephone calls, online 
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support, and follow-up; resources from the AHA and NIH were also helpful to keep participants 
on track. Teaching was applied during the initial counseling session with teachback methods. 
Topics of discussion were the physiology of cholesterol, blood pressure, genetics, and weight to 
correlate how each affects the role of health in the body. Nursing intervention depends on 
patient preferences and response to their environment. Discharge or follow up to care happens 
when participants are able to make lifestyle choices that impact longevity and quality of 
cardiovascular health. Nursing actions should be based on patient response, to adapt and assist 
patient where they’re at on the health continuum and move them toward wellness and evidence-
based research that utilize nursing theories and goals, which is essential for Orem’s theory.  
Research 
 Although this project was evidence-based, there are gaps in the literature regarding 
further clinical investigation for adult patients with established CAD. New guidelines were 
published from the ACC/AHA during the implementation process regarding the management of 
blood cholesterol. With these new guidelines in place, further research should investigate the 
percentage of LDL-C reduction in patients who are at higher risk for developing CAD or 
experiencing a secondary cardiac event. A multidisciplinary, multifactorial intervention that 
utilizes telehealth or electronic technology, such as smart phone applications may be beneficial 
for those patients at risk for developing CAD or high ASCVD risk percentages. The use of 
electronic technology and resources may provide better accountability due to programming 
reminders and ease of downloading applications and typing into one central location to access a 
variety of resources. Future research should be developed on the use of a multidisciplinary 
team and relevant environmental resources to assist patients with healthier lifestyle choices on 
a primary prevention level.  
Education 
 Education impacts both the advanced practice and professional nurse. The family nurse 
practitioner can further explore patient’s risk factors, current lifestyle choices, family history, and 
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available options to discuss with patients during annual wellness or follow-up visits. Family 
nurse practitioners are first line agents to advocate for lifestyle interventions at the 
organizational level. This process calls for the practitioner to be a lifelong learner by constantly 
reviewing newly released research and EBP and presenting the information to patients and 
obtaining feedback to present to organizational administration for implementation. For the 
professional nurse, the findings from this EBP project could be used to educate patients in the 
clinical setting- either in a practice office or acute care setting. The significant role EBP plays in 
the development of patient resources that promote cardiac care and how to access these 
resources through a hospital organization. The professional nurse can also address the 
immediate needs of the patient and modify the intervention based on the context of the patient’s 
environment and access to resources. With education playing a role in EBP, nursing educators 
can emphasize and teach the importance of professional nurses to educate patients and what 
impacts their healthcare decisions. As well as the APN, who is the patient’s biggest advocate 
and access to resources. Resources consist of providing local dieticians, lifestyle programs, 
fitness activities, grocery store selection, and restaurants, as well as online support and groups.  
Conclusion 
 In conclusion, the lifestyle prevention of secondary cardiac events would not only 
decrease mortality worldwide, but also improve cardiac disparities and disease progression. 
This EBP project addressed the clinical problem by lowering or maintaining therapeutic LDL-C 
levels. The literary synthesize was supported by 16 pieces that emphasized a focus on altering 
lifestyles; these literary pieces included systematic reviews, randomized control trials, literature 
reviews, and clinical guidelines. Melynk and Fineout-Overholt (2015) was used to evaluate the 
hierarchy of evidence, and the Johns Hopkins Nursing Research/Non-Research Evidence 
Appraisal tool (2014) was used to appraise the evidence with guidance of the Stetler model for 
EBP process and Nola Pender’s Health Promotion model. The overall best practice 
recommendation was a multifactorial lifestyle modification program. An intervention was created 
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from the literature which included counseling, education, LDL-C levels, BP, and BMI monitoring, 
and dietary and physical activity assessment over six months. The clinical question was 
answered and compelling findings included the significance of behavioral changes associated 
with advocating and educating patients on a heart healthy lifestyle. Self-efficacy was apparent 
through all the participants who completed the intervention. It was apparent through compliance 
of completing the self-guided booklet, maintaining therapeutic LDL-C levels, and improvement in 
dietary and physical activity scores. These inferences can be used as support for future 
implications for nursing practice changes in the clinical setting, theory development, further 
research, and education. This intervention can be used in clinical practice to prevent the 
incidence of secondary and possibly primary cardiac events, reducing overall mortality of one of 
the most fatal diseases.  
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Appendix A 
 
Synthesis of Evidence  
 
Citation (APA) Purpose Design 
 
Sample Measurement/ 
Outcomes  
 
Results/Findings Level/ 
Qualit
y  
Al Mheid et al. 
(2016) 
 
Effects of a health-
partner intervention 
on cardiovascular 
risk 
 
Journal of the 
American Heart 
Association  
Health-
partner 
administered 
lifestyle 
intervention 
on CV risk 
profile 
Prospective 
cohort study  
 
Intervention: 
counseling 
given by a 
health-partner 
on healthier 
lifestyles on CV 
risk factors 
(AHA Life’s 
Simple 7) 
 
Participants 
given 
questionnaires 
regarding diet 
and physical 
activity  
n = 711 
University 
employees  
 
 
Duration: 
over 2 years- 
baseline, 6-
months, 1-
year, and 2-
years 
Physical 
measurements: 
vital signs, 
height/weight, 
and waist hip ratio 
 
Lipid panel 
 
Metabolic panel  
Decrease in SBP and DBP at 6 
months (-3.6 mmHg and -2.2 
mmHg, p<0.0001) 
 
Improvement in LDL-C 
(p<0.001) 
 
Physical activity increased by 
6% at 6 months(P=0.04) 
 
Dietary changes improved, 
scores increased by 0.46 with 
baseline poor diet scores at 6 
months (P<0.001) 
 
IV, A 
Cole, Smith, Heart, 
& Cupples (2011) 
 
Systematic review 
of the effect of diet 
and exercise 
lifestyle 
“to determine 
the 
effectiveness 
of lifestyle 
interventions 
for the 
secondary 
Systematic 
review pf 21 
RCTs; meta-
analysis with 
95% CI 
 
n = 10,799 
 
Adults ages 
18 years or 
older 
 
Primary 
outcomes: 
All-cause 
mortality, cardiac 
mortality, nonfatal 
cardiac events, 
Diet: 39 out of 51 outcomes 
were significant in dietary 
improvement to include 
improvement for intake of fiber, 
fat, sugar, and cholesterol 
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interventions in the 
secondary 
prevention of 
coronary heart 
disease 
 
Cardiology 
Research and 
Practice 
 
prevention of 
coronary 
heart 
disease”  
(Cole et al., 
2011, p. 2) 
Setting: 
outpatient 
clinical setting 
or home-based 
interventions 
 
Interventions: 
dietary, 
exercise, 
psychological, 
educational, 
multifactorial, 
organizational 
Duration: 3 
months to 5 
years with 
follow-up 
every 3 
months 
hospital 
admissions 
 
Secondary 
outcomes: 
Diet (intake of 
fiber, fruits, & 
vegetables), 
exercise, blood 
pressure, blood 
lipid levels, health 
related quality of 
life, self- efficacy, 
and medication 
adherence 
 
Physical Activity: 20 studies 
showed significant 
improvements in workload  
 
Blood pressure: 5 out of 13 
studies reported benefits at 3 
months and 12 months 
 
LDL-C: 5 studies reported 
significant improvements 
 
Self-efficacy: reported in 1 
study, significant improvement 
in self-management at 6-month 
follow-up 
de Waure et al. 
(2013) 
 
Lifestyle 
interventions in 
patients with 
coronary heart 
disease: A 
systematic review 
 
American Journal of 
Preventive Medicine  
 
Reduce risk 
for fatal and 
nonfatal CV 
events with 
established 
CHD 
Systematic 
review of 14 
RCTs; meta-
analysis, groups 
compared with 
RR, 95% CI 
 
Setting: 
Telephone-
based, 
outpatient 
setting, or home 
 
Intervention: 
Multifactorial 
lifestyle 
components 
n = 6,657 
 
Patients with 
established 
CHD 
 
Duration: at 
least 6 
months 
Primary 
outcomes: fatal 
and nonfatal CV 
events (MI, 
revascularization, 
and death) 
 
Secondary 
outcomes: overall 
mortality and 
hospital 
readmissions 
Multifactorial lifestyle 
interventions should be 
considered in secondary 
prevention programs 
 
Reduced fatal CV events with 
estimated RR 18%; (RR= 0.82, 
95% CI = 0.69, p = 0.003) 
 
Reduced overall mortality; RR 
0.94, 95% CI = 0.83, 1.06; p = 
0.32) 
 
Improvement in risk factors for 
home-based interventions: 
Decrease in SBP WMD (-4.36 
mmHg, 95% CI = -6.50, -2.22) 
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(reducing blood 
pressure, LDL-
C, blood 
glucose, 
smoking, 
physical activity, 
stress, and 
weight) and 
patient-tailored 
 
Total cholesterol WMD (-0.33, 
95% CI= -0.57, -0.08) 
 
 
 
Drakopoulou et al. 
(2016) 
 
Managing lipid 
profile of coronary 
heart disease 
patients 
 
Expert Review of 
Cardiovascular 
Therapy 
“summary of 
current 
recommendat
ions for lipid 
profile 
management 
in patient with 
CHD, with 
view to 
present 
lifestyle 
modification 
and novel 
treatment 
strategies 
indicating 
also the 
areas of 
dispute 
between 
recent 
guidelines” 
(Drakopoulou 
Expert opinion 
on the 
guidelines 
established by 
the ACC/AHA 
and European 
Society  
Lifestyle and 
treatment 
therapies for 
patients with 
coronary 
heart disease 
Focus on lipid 
levels, blood 
pressure, 
European Society 
recommends 
adding behavioral 
and psychosocial 
risk factors, 
smoking 
cessation, and 
body weight 
control 
Increase vegetable, fiber, 
whole grains, low-fat dairy, 
poultry, legumes, fish, and nuts 
for dietary improvements  
 
Stress the importance of daily 
exercise (reduces LDL-C by 3-
6 mg/dL when performed for 24 
weeks in duration, greater than 
3 days per week for 40 
minutes) 
 
Obtain secondary lipid panel at 
4-12 weeks after initiation of 
statin therapy or change in 
therapy to further determine 
patient’s adherence (then 
perform every 3-12 months) 
 
No emphasized LDL-C target 
goals 
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et al., 2016, 
p. 1263) 
Eckel et al. (2014)  
 
2013 AHA/ACC 
guideline on lifestyle 
management to 
reduce 
cardiovascular risk 
 
Journal of the 
American College of 
Cardiology 
“prevent 
CVDs, 
improve 
management 
of people 
who have 
these 
diseases 
through 
professional 
education 
and research; 
and develop 
guidelines 
and 
standards 
and policies 
that promote 
optimal 
patient care 
and CV 
health” (Eckel 
et al., 2014, 
p. 2961) 
Expert Work 
Group with 16 
members 
(expert panel) 
 
Guideline 
developed that 
includes data 
from RCTs, 
observational 
studies, 
systematic 
reviews with 
meta-analysis 
For patients 
who are at 
risk or have 
CVD 
Effects on total 
cholesterol, LDL-
C, blood 
pressure, levels 
of aerobic activity, 
and dietary habits 
Emphasized focus on low fat 
dietary patterns (decrease in 
fats- as a macronutrient, i.e. 
DASH diet, Mediterranean diet) 
 
Dose dependent inverse 
relationship between levels of 
physical activity and rates of 
CVD and beneficial effects on 
lipids, cholesterol, and blood 
pressure  
 
10 Lifestyle recommendations 
(p. 2968- 2970) 
 
VII, A 
Hooper, Martin, 
Abdelhamid, & 
Smith (2015) 
 
Reduction in 
saturated fat intake 
Discover the 
effects on 
health of 
cutting down 
on saturated 
fat intake  
Systematic 
review; meta-
analysis with 
RR for 
dichotomous 
data and MD for 
continuous data 
15 RCTS  
 
n = 759,000 
Adults with or 
at risk for 
CVD 
 
Primary 
outcomes: 
All-cause 
mortality, CVD 
mortality, CVD 
events 
No clear effects on all cause or 
CVD mortality 
 
13% reduction in CHD events 
(RR 0.87, 95% CI 0.74 to 1.03) 
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for cardiovascular 
disease 
 
Cochrane Database 
of Systematic 
Reviews 
 
 
Intervention: 
modified fat 
diets compared 
with usual diets  
 
Duration: at 
least 2 years 
Secondary 
outcomes: 
Fatal and non-
fatal cardiac 
events, blood 
lipids, cancer, 
blood pressure, 
BMI, body weight, 
and quality of life 
 
LDL-C sig. reduction (MD -0.19 
mmol/L, 95% CI -0.33 to -0.05)  
 
Significant reduction in SBP 
(MD -0.19 mmHg, 95% CI -1.36 
to -0.97) and DBP (MD -0.36 
mmHg, 95% CI -1.03 to 0.32) 
 
Significant difference in BMI 
(MD -0.50, 95% CI, -0.82 to -
0.19) 
Kotseva et al. 
(2016) 
Euroaspire IV: A 
European Society of 
Cardiology survey 
on the lifestyle, risk 
factor and 
therapeutic 
management of 
coronary patients 
from twenty-four 
European countries  
 
European Journal of 
Preventive 
Cardiology 
Identify 
patient risk 
factors, 
describe 
management 
through 
lifestyle and 
drug 
therapies, 
and provide 
objective 
assessment 
of clinical 
implementati
on of current 
scientific 
knowledge 
Cross-sectional 
study  
 
Collected data: 
Medical records 
and interviews  
 
 
n = 16,426 
medical 
records 
reviewed 
 
n = 7,998 
patients 
interviewed 
 
Patients < 80 
years old with 
CD who had 
CABG, PCI, 
or ACS 
 
Duration: 6 
months 
Lifestyle risk 
factors and 
therapeutic 
targeted 
measures 
 
Physical activity 
 
Waist 
circumference 
 
Blood pressure 
 
LDL-C 
 
Smoking habits 
 
Cardioprotective 
medications 
 
Diabetes 
 
Physical activity increased by 
followed advice from a health 
or exercise professional 
(23.5%), attended a gym or 
exercise program (52.8%) 
Increased daily physical activity 
(17.4%) 
 
Knowledge of weight (93.4%) 
and blood pressure (86.7%) 
 
Unaware of cholesterol (48.9%) 
and waist circumference 
(29.3%) 
 
Patients on lipid lowering 
medications (86.6%), mainly 
statins (85.7%) 
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Cardiac rehab 
attendance 
Noe, Dosa, Ranky, 
& Pavlik (2014) 
 
Cardiovascular 
results of an 
individually 
controlled complex 
prevention  
 
Acta Physiologica 
Hungarica  
 
“To study the 
effect of a six- 
month regular 
training 
program of 
two different 
intensities on 
patients with 
previously 
existing risk 
factors (Noe 
et al., 2014, 
p. 2) 
Quasi-
experimental 
 
Patients 
followed lifestyle 
modification and 
nutrition and 
separated into 3 
groups for 
training 
sessions 
Group A: 
combined 
(aerobic and 
resistance) 
training 
sessions four 
times per week  
 
Group B: 2-3 
times per week 
 
Group C: no 
regular physical 
activity  
n = 75 
patients with 
risk factors  
 
3 groups 
A & B n = 50 
 
C n = 25 
 
Duration: 6 
months 
 
 
Blood pressure 
 
Heart rate 
 
Lipid profile 
 
BMI 
 
Exercise tests 
BMI significantly decreased:  
Group A > Group B (8.7% 
versus 5.0%) 
 
Reduction in BP: 
Group A resting SBP and DBP 
decreased by (8.5% and 7.0%, 
respectively)  
Group B reduction was smaller 
(5.5% and 4.7%) 
 
LDL-C decreased (Group A 
29.8% vs Group B 21.2%) 
 
III, A 
Rees et al. (2013) 
 
Dietary advice for 
reducing 
cardiovascular risk 
(review) 
Addresses 
the effect of 
dietary advice 
among 
healthy 
people to 
Systematic 
review of 44 
RCTs; meta-
analysis with 
95% CI  
 
n = 18,175  
 
Healthy 
adults with 
cardiovascula
r risk factors  
Primary 
outcomes: CV 
risk factors, blood 
pressure, lipids, 
and biomarkers of 
dietary intake 
Blood pressure was reported in 
11 studies; SBP reduced by 
2.61 mmHg (-2.61, 95% CI -
3.91 to – 1.31) DBP reduced by 
1.45 mmHg (-1.45, 95% CI -
2.22 to – 0.68) 
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Cochrane Database 
of Systematic 
Reviews 
 
establish 
relevance in 
clinical 
practice 
Setting: Clinical 
healthcare 
 
Interventions: 
verbal or written 
advice delivered 
in person 
 
Duration: 3 
months to 12 
months 
 
Secondary 
outcomes: self-
reported dietary 
intake 
 
Lipids reported in 18 studies: 
small but significant reduction 
in total cholesterol 0.15 mmol/L 
(difference means -0.15, 95% 
CI -0.23 to – 0.06) 
LDL-C reduced in 13 studies; 
0.16 mmol/L (-0.16, 95% CI -
0.24 to -0.08) 
 
DASH diet resulted in largest 
reduction of fat intake of 
10.9%; saturated fat reduced 
by 2.39% (-2.39, 95% CI -3.37 
to – 1.4) 
Rippe & 
Angelopoulous 
(2014)  
 
Lifestyle strategies 
for cardiovascular 
risk reduction 
 
Current 
Atherosclerotic 
Report 
Summarize 
recent 
literature 
review to how 
specific 
lifestyles 
strategies 
may be 
employed to 
lower risk of 
CV disease 
Literature 
review on the 
AHA Strategic 
Plan for 2020 
Patients who 
have or at 
risk for CVDs 
Discuss BMI 
(weight), amount 
of physical activity 
per week, blood 
pressure, dietary 
type/patterns, and 
smoking habits 
Overall, counseling patients 
that lifestyle changes can 
produce modest to sustained 
weight loss and achieve 
meaningful health benefits, 
thus reducing CV risk 
 
DASH diet adherence improves 
CV health 
 
Physical activity 
recommendation of 3-4 
sessions of physical activity at 
40 minutes per session of 
moderate to intense aerobic 
and resistance exercise 
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Discontinue targeted treatment 
LDL goals; 4 major statin 
benefit groups 
 
JNC 8 recommendations of 
regular aerobic exercise, 
limiting salt, maintain a healthy 
body weight, and smoking 
cessation for blood pressure 
management 
Salehi- Abargouei et 
al. (2013)  
 
Effects of Dietary 
Approaches to Stop 
Hypertension 
(DASH)- style diet 
on fatal or nonfatal 
cardiovascular 
disease- Incidence: 
A systematic review 
and meta-analysis 
on observational 
prospective studies 
 
Nutrition 
“. . . 
summarize 
the 
information 
and assess 
the 
magnitude of 
the relation 
between 
imitating a 
DASH-style 
diet and 
CVDs or its 
major 
subclass like 
CHD, stroke, 
and HF in 
prospective 
cohorts” 
(Salehi-
Abargouei et 
al., 2013, p. 
612) 
Systematic 
review; meta-
analysis  
using calculated 
RR and its SE, 
with 95% CI, 
P <0.05 
 
6 cohort studies 
 
Intervention: 
Imitating DASH 
style diet  
 
 
 
n = 260,011 
 
Adults with or 
at risk for 
CVD 
 
 
Incidence of 
CVDs, CHD, or 
stroke  
3 out of the 6 studies included 
data in relation to CHD 
 
In 144, 337 adults eating DASH 
diet can lower risk for CHD 
(RR 0.79, 95% CI, 0.71-0.88, P 
<0.001) 
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Stone et al. (2014) 
 
2013 ACC/AHA 
guidelines on the 
treatment of blood 
cholesterol to 
reduce 
atherosclerotic 
cardiovascular risk 
in adults 
 
Journal of the 
American College of 
Cardiology 
 
 
“define 
practices that 
meet the 
needs of 
patients in 
most 
circumstance
s . . .” (Stone 
et al., 2014, 
p. 2891) 
 
 
Expert panel 
(16 members) 
 
NHLBI 
systematic 
evidence review 
which consists 
of RCTs, 
systematic 
reviews with 
meta-analysis of 
RCTs 
 
 
Intended for 
the treatment 
of adults ages 
21 years or 
older to 
complement 
the NHLBI 
CV health 
risk-reduction 
guidelines 
 
 
Blood cholesterol 
panel 
 
 
Lifestyle is the foundation for 
ASCVD risk factors 
 
Recommended guideline: 
4 major statin benefit groups 
p.2897 
No specific targeted LDL-C 
goal 
Secondary prevention- high 
intensity therapy most 
beneficial for patients less than 
or equal to 75 years of age 
 
VII, A  
Stuart et al. (2013) 
 
A telephone-
supported 
cardiovascular 
lifestyle programme 
(CLIP) for lipid 
reduction and 
weight loss in 
general practice 
patients: A 
randomised 
controlled pilot trial 
 
Public Health 
Nutrition 
 
“. . . evaluate 
a primary 
prevention 
care model 
using 
telephone 
support” 
(Stuart et al., 
2013, p. 641) 
RCT pilot trial 
 
Intervention: 
handbook with 
dietary meal 
plans, recipes, 
and physical 
activity plans 
and telephone 
based coaching 
sessions 
 
Control: usual 
care and 
general lifestyle 
handouts 
 
Intervention 
(CLIP) n = 26 
 
Control  
n = 23 
 
Duration: 12 
weeks 
 
 
LDL-C 
 
Waist 
circumference 
 
Blood pressure 
 
Physical activity 
 
Motivation 
No changes in BP or 
cholesterol meds over course 
of study 
 
CLIP participants demonstrated 
significantly greater reductions 
in LDL-C with significant main 
effect for treatment on LDL-C 
(F (1,43) = 15.50, P = 0.001) 
 
No significant effect on blood 
pressure- stable throughout 
study 
systolic (F (1, 45) = 0.28, P = 
0.60) or diastolic (F(1, 43) = 
0.52, P = 0.47) 
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 CLIP participants experienced 
weight loss but not significant, 
no significant treatment effect 
on waist circumference; 
however, positive correlation 
between weight loss and LDL-
C (r = 0.560, n 26, P = 0.003) 
Tapsell & Neale 
(2016) 
 
The effect of 
interdisciplinary 
interventions on risk 
factors for lifestyle 
disease: A literature 
review 
 
Health Education 
and Behavior 
“Examine 
evidence of 
interdisciplina
ry 
interventions 
on lifestyle 
disease risk 
factors 
including 
weight, lipid 
level, 
glycemic 
control, and 
blood 
pressure to 
summarize 
the 
characteristic 
features of 
successful 
interventions” 
(Tapsell & 
Neale, 2016, 
p. 272) 
Systematic 
review; meta-
synthesis 
 
16 studies 
RCTs= 7 
Pseudorandomi
zed(not truly)= 3 
Pre &Post test 
results without 
comparisons to 
a control group  
n = 15,890 
adults with 
chronic 
disease 
Weight 
 
Lipid levels 
 
Hemoglobin A1c 
 
Blood pressure 
 
Characteristic 
features of 
successful 
interventions 
1 of 6 studies found greater 
improvements in blood lipids 
 
5 studies found reductions in 
blood pressure 
 
Greater effects seen where 
there was a greater amount of 
contact between health 
professionals and participants 
 
The addition of exercise and/or 
behavior modifications to 
dietary advice resulted in 
significant reductions in body 
weight and improvements in 
blood pressure  
 
Weekly contact produced 
positive outcomes- ongoing  
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van den Wijngaart, 
Sieben, van der 
Vlugt, de LeeuW, & 
Bredie (2015) 
 
A nurse-led 
multidisciplinary 
intervention to 
improve 
cardiovascular 
disease profile of 
patients 
 
Western Journal of 
Nursing Research 
“. . . evaluate 
the 
magnitude of 
change in 
various 
modifiable 
cardiovascula
r risk factors, 
such as body 
mass index, 
waist, blood 
pressure, 
lipid levels, 
and lifestyle 
parameters, 
during short- 
and long-term 
follow-up” 
(van den 
Wijngaart, 
2015, p. 707) 
Quasi-
experimental 
- one treatment 
group  
 
Intervention: 
Evaluation of 
risk profile and 
individualized 
treatment plan 
was 
implemented, 
including both 
pharmacological 
and lifestyle 
behavior 
change  
n = 176 
 
Patients with 
CVD  
 
Setting: 
outpatient 
clinical setting 
 
 
Duration: 3 -
15 months; 
LDL-C, BMI, 
and BP were 
monitored at 
3 and 6 
months 
 
 
Baseline 
characteristics: 
age, gender, BP, 
BMI, LDL-C, waist 
circumference, 
smoking habits, 
alcohol usage, 
and eating habits 
 
Differences 
measured by 
univariate 
ANOVA 
 
Effect of 
intervention 
measured by 
paired t - test or 
chi-squared  
Significant reduction in SBP 
(138.3  20.7 mmHg to 128.7  
17.7 mmHg;  
p <0.01) 
 
Significant reduction in LDL-C 
(2.55  0.87 mmol/L to 2.16  
0.73 mmol/L;  
p <0.01)  
 
Less patients became physical 
activity toward end of study 
 
BMI increased from 26.6  4.5 
to 27.5  
 4.8 kg/m2  
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Appendix B 
Rate-Your-Plate for Blood Cholesterol (RYP) tool
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Appendix B (continued) 
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Appendix B (Continued) 
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Appendix C 
Rapid Assessment of Physical Activity (RAPA) tool 
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